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Introduction
Many anticancer therapies are based on the interactions of drugs with DNA. By bind-
ing covalently or non covalently to DNA, drugs may inhibit replication, shield the
adducts from nucleotide excision repair, and interfere with transcription by recruiting
essential transcription factors from their native binding sites, thus causing the death
of cancerous cells. Sequence-specificity and affinity of drugs and proteins towards
particular DNA-sequences relies on sequence dependent deviations from canonical
B-DNA. For example, DNA sequences containing A-tracts are intrinisically bent as
shown by gel-electrophoresis and electron microscopy [1, 2]. These sequence depen-
dent variations can be used as finger prints by proteins and drugs, which recognize
and bind selectively to specific DNA-sequences.
Molecular modeling based on effective potentials has proven to be of great help
in characterizing the structure, dynamics and energetics of DNA in the free state[3]
[4]. and in complex with proteins [5, 6] and small molecules [7]. In fact, the develop-
ment of realistic force fields and protocols is allowing ever larger systems (including
DNA/protein complexes) to be studied for simulation times that can reach the 100-ns
time-scale. Still, despite the successes, there are several areas of DNA-modeling in
which the use of effective potentials may encounter difficulties. This is due to the
fact that there is a large class of phenomena that depend on the electronic structure
in such an intricate way that they cannot be modeled via effective potentials. One
of such areas is the description of transition metals/DNA complexes, where subtle
chemical phenomena play a significant role, such as the ligand field and the fact that
the metal ion ligand bond has a partially covalent nature. Another area deals with the
description of bond breaking-bond forming processes, which come into play in the
binding of drugs which forms covalent bonds to DNA.
An alternative to investigate such systems is offered by QM/MM approaches, in
which the lesion is treated at the quantum chemical level and the biomolecular frame,
including the solvent and the counter ion, is treated with an effective potential [8, 9,
10]. In the case of DNA, the solvent environment has been shown to be absolutely
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essential for the electronic properties [11, 12].
Here we present the first application of such methodologies to drug/DNA adducts.
We use the novel Car-Parrinello/MM approach[13, 14], which has been widely used
in the context of protein catalysis[15, 16, 17, 18]. This method appears to be very
well suited as:
• Drug-DNA interactions are described accurately without the need for new force
field parameters. This is particularly important in drugs involving transition
metals, such as cisplatin, where the exact coordination geometry depends on the
electronic structure of the metal-DNA complex, which is difficult to describe
by classical force-fields.
• Chemical reactions between the drug and the DNA can be simulated taking
into account the entire biomolecular frame. Inclusion of the entire DNA envi-
ronment is even more important than in protein catalysis since the electrostatic
potential of the highly charged DNA double helix polarizes the drug signifi-
cantly and may change its reactivity.
• Dispersion interactions are better described by the classical force-field than by
DFT. Thus, including stacking energies by the classical force-field has actually
an advantage over a full QM treatment.
Thus, a quantum chemical, parameter free approach for the drug-containing moieties
in combination with well-established potentials for the macromolecular frame is not
only very useful but necessary when discussing the origin of DNA catalytic activity.
The QM/MM method used here has been developed in the lab of Prof. Röthlis-
berger [19, 13, 14], and it has already been used succesfully to describe chemical and
enzymatic reactions by the group in SISSA [15, 20]. The projects discussed in this
thesis are carried out in collaboration with the group of Prof. Röthlisberger.
In my thesis I will discuss several aspects of drug-DNA interactions. I will present
two conceptually very different anticancer drugs, belonging to two important classes
of compounds: The first is cisplatin, which is one of the first anticancer drugs that
entered clinical treatment and which has lived an unreached story of success in the
treatment of cancer. Since its discovery in the 60’s, intense research on cisplatin
and its derivative has provided a wealth of experimental and theoretical data giving
insights into the kinetic and structural behavior of cisplatin-DNA complexes. There-
fore, we can validate our method by comparison to published work.
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The second drug belongs to the class of duocarmycins, derived from a natural
antibiotic, which binds specifically to the minor groove of DNA. The natural prod-
uct has shown to have antitumoral activity and currently one derivative has entered
clinical test phases [21]. Duocarmycins are very stable in solution, but undergo a re-
markable activation upon DNA-binding. The origin of catalytic activity is still under
debate and several hypotheses including conformational changes in both the drug and
the DNA have been discussed. The QM/MM approach along with a variety of other
computational tools allows to investigate both large scale dynamics of the complex,
the binding and the alkylation reaction and to elucidate the origin of catalytic activity
in DNA. The quantum simulations will be complemented by classical MD in order to
investigate conformational changes in DNA upon drug binding before the alkylation
reaction, as well as the hydration and structural flexibility of DNA in solution. We
will show that these results are useful to explain differences in reactivity and they
provide further information for future drug-design.
My thesis is divided into five chapters as follows:
• Chapter I consists of a brief history of DNA structure elucidation followed by
an explanation of DNA structure and nomenclature according to the IUPAC
definitions.
• In Chapter II I present the methods used, i.e. classical molecular dynamics
and hybrid QM/MM molecular dynamics with emphasis on the application to
nucleic acids.
• Chapter III deals with the interaction of cisplatin with DNA, which I studied by
means of QM/MM molecular dynamics simulation. This study both illuminates
differences between the crystal and solution structure of the drug-DNA adduct
and validates the new approach for modeling Pt/DNA interactions.
• Chapter IV investigates the origin of DNA catalytic activity towards duocarmycin.
Duocarmycin is a minor groove binder, which alkylates DNA at specific ade-
nine sites. Both classical and QM/MM molecular dynamics simulations are ap-
plied to explain the reaction mechanism and differences in reactivity between
several derivatives.
• Chapter V summarizes the results and present a short outlook of ongoing work,
which is based on the results obtained from the study of duocarmycin binding
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to DNA. It contains a qualitative picture of the dissociation of different duo-
carmycins from the DNA minor groove, obtained by means of steered molecu-
lar dynamics.
Chapter 1
Some facts about Nucleic acids
In the early 1950’s not much was know about DNA structure. New techniques, such
as X-ray crystallography just started to be introduced in structure analysis of bio-
logical molecules. Rosalind Franklin, a new research associate in John Randalls lab
at Kings College, was given the task to elucidate DNA structure by this technique.
She was the first scientist to discover that the phosphate-ribose backbone lies at the
outside of the DNA molecule and she also elucidated the basic helical structure of
the macromolecule. Her knowledge was a fundamental key in the breakthrough of
DNA structure elucidation by Watson and Crick. Another piece in the jigsaw puzzle
was Chargaff’s 1:1 relationship between the adenine-thymine and guanine-cytosine
content, which resulted to be of general validity in all organisms [22]. Crick realized
that this quantitave relationship could be caused by complementary base-pairing be-
tween adenine and thymine and guanine and cytosine, respectively and he envoked
the hydrogen bonding pattern now known as Watson-Crick hydrogen bonds (Figure
1). Based on this information, Watson and Crick proposed a model of a right-handed,
antiparallel double helix, in which the phosphate-ribose backbone lied at the outside
of the helix and the bases pointed towards the center of the helix, held together by
these specific hydrogen bonds. This leads to several obsevations:
• The charged phosphate groups are solvent exposed and can therefore easily be
neutralized.
• The base-pairing rule offers a simple copying mechanism: One strand serves as
a template, and the missing strand can be reconstructed thanks to the recogni-
tion of the complentary base by hydrogen bonding.
The structure proposed by Watson and Crick is now known as B-DNA. In ideal B-
DNA, the base-pairs are perpendicular to the helix axis and twisted by ∼36◦ with
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Figure 1.1: Watson-Crick base pairing. Top: Adenine(A) with Thymine (T), Bottom: Gua-
nine(G) with Cytosine(C).
respect to each other. Therefore 10 base pairs constitute an entire turn in the double
helix. The two strands of the double helix are separated by two distinct grooves: the
minor groove and the major groove. The narrow minor groove contains ordered water
molecules, which form a characteristic hydration pattern, either a spine of hydration
(A-tracts) or a ribbon of hydration (normal DNA-sequences). The correctness of the
model was ultimately prooved by X-ray crystallography. In 1952, Rosalind Franklin
discovered by the same technique different forms of DNA, the dry and the wet form,
now known as A-DNA and B-DNA (Figure 1.2).
The dry A-DNA is a right-handed double helix in which hydrophobic stacking
interactions between base-pairs are optimized by an inclination of the base-pair plane
with respect to the helix axis of 19◦. This leads to a wider minor groove, which lacks
a spine of hydration and a very deep major groove (Table 1. The sugar conformation
changes from C2’-endo as found in B-DNA to C3’-endo (Figure 1.3).
This conformational change distances the phosphate groups in a way to avoid
autocatalysis. Other DNA forms have been detected since such as the left handed
Z-DNA (Figure 1.2). The form under which DNA is present depends mainly on
environmental effects such as the degree of hydration, salt content and the exact com-
position of the solution. With the advance of experimental techniques, such as X-ray
crystallography, NMR spectroscopy, gel-electrophoresis and electron microscopy, de-
7Figure 1.2: Schematic drawing of A-DNA (left), B-DNA (middle) and Z-DNA (right).
Figure 1.3: Sugar pucker as found in A-DNA (left) and in B-DNA (right).
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Figure 1.4: Numbering in DNA and RNA bases according to IUPAC.
viations from the ideal A and B-DNA structures were detected. There was growing
evidence that these deviations were at least partially sequence dependent, indicating
a possible way of sequence specific DNA recognition by proteins and drugs [23, 24].
It also became clear that a universal set of structural parameters was mandatory in
order to describe precisely and unequivocally the structural features of a given DNA
molecule. In the early 70’s an effort has been made to elaborate a nomenclature of
general validity for nucleic acids, which is now recommended by IUPAC, the Joint
Commission on Biochemical Nomenclature [25, 26, 27, 28] (see also the following
helpful links [29, 30]) and in the following I will give the definitions, which are most
relevant to the discussion that follows.
The nucleobases can be divided into the purines adenine (A) and guanine (G) and
the pyrimidines cytosine (C) and thymine (T) or uracyl in RNA (U). The numbering
of the atoms in the nucleobases is given in Figure 1.4.
The atoms in the phosphate-ribose backbone are distinguished from the ones in
the bases by a prime. The sugar ring is attached to the N9 position in purines and to
the N1 position in pyrimidines via a glycosylic C-N bond. The torsional angle around
the glycosylic bond is denoted χ and defines the orientation of the nucleobase with
respect to the sugar ring, which can be eiter syn or anti. In standard B-DNA the bases
are usually in the anti-conformation, which is sterically more favorable.
The sugar ring is not planar but can adopt different conformations, in which one or
two atoms are displaced from the plane described by the other atoms. If the “out-of-
plane” atom lies on the same side as C5’ it is called endo, if it lies on the other side
it is called exo. The most common conformations are C2’-endo, present in canonical
B-DNA, and C3’-endo, which is usually met in A-DNA. A more complete picture
is given by the pseudorotation cycle as described for example in [31]. The obtained
angles can be linked to the more approximate endo-exo definition by means of the
sugar wheel (Figure 1.5).
9Figure 1.5: Pseudorotation cycle of the furanose ring in nucleosides. Values of the phase
angles are given in multiplets of 36◦.[31]
10 Some facts about Nucleic acids
Figure 1.6: Atomic numbering scheme and definitions of torsional angles in phosphate-sugar
moiety in RNA (valid also for DNA, besides that O2’ is substituted by H2’).[31]
Further torsional angles along the phosphoester bonds are called α, β, γ, δ,  and
ζ shown in Figure 6.
The orientation of the bases and base-pairs with respect to each other is described
by the helical parameters (Figure 1.7). These parameters can be divided into groups
according to the geometrical features they describe:
• Parameters describing the relative orientation of two bases in the same base-
pair: Shear, Stretch, Stagger, Propeller twist, Buckle and Opening.
• Parameters, which consider the relative orientation of two adjacent base-pairs:
Roll and Tilt angle, Shift, Slide and Rise as well as helical Twist angle.
• Parameters which describe the orientation of a base-pair to a primarily defined
global helix-axis: X-and Y displacement, Inclination and Tip
The measurement of these structural parameters require the definition of an axis sys-
tem for each base and base-pair as well as the determination of a global helix axis.
This task is solved by several analysis programs but usually the determination of the
local and global reference frames is not unequivocal, leading to slightly different re-
sults concerning the above parameters. In particular, the determination of a global
axis requires special attention since large distortions in the double helix can lead to
difficulties in the determination of a straight helix axis. In this work, we use mainly
the analysis program Curves, written by Richard Lavery and Heinz Sklenar [32, 33].
11
x
x
x
x
x
x x
x
x
x
x
x
x
x
x
x
y
y
y
yy
yy y
y
y
y
y
y
y
yy
y
z
z
z
zz
zz z
z
z
z
z
x
z
z
zz
z
Propeller
Opening
Buckle
Stagger
Shear
Stretch
Shift
Slide
Rise Twist
Roll
Tilt
x−displacement inclination
y−displacement tip
Images created with 3DNA
illustrating positive values
of designated parameters
3’
5’
5’
3’
III Coordinate frame
Figure 1.7: Schematic drawing of distortion between bases and base-pairs described by he-
lical parameters.
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Residues Twist per Rise per Sugar
per turn base-pair [◦] base-pair [Å] pucker
B-DNA 10 36 3.3-3.4 C2’-endo
A-DNA 11 32.7 2.9 C3’-endo
Minor groove Major groove
width depth width depth
B-DNA 5.7 7.5 11.7 8.8
A-DNA 11.0 2.8 2.7 13.5
Table 1.1: Selected parameters for right handed DNA double helixes
In this program, an optimal curvilinear axis is determined by optimizing a suited geo-
metrical function containing four variables for each base, namely the X-displacement,
Y-displacement, Inclination and Tip.
Changes in the structural parameters of DNA are often correlated due to geomet-
rical restrictions of the sugar/phosphate backbone. This becomes for example evident
in case of a large helical twist, which stretches the backbone. The stretch is par-
tially relieved by bringing the base-pairs closer together, lowering thus the rise. This
correlation has been quantified by Yanagi et al.[34] in the profile sum:
Profilesum = (ω − 36)− 16.24(Dz − 3.36) + 0.744χ− 0.703ρ (1.1)
In case of large twist and low rise one is in the region of High Twist Profile (HTP)
and in case of low twist and large rise one is in the region of Low Twist Profile (LTP).
Finally, minor and major groove width and depth are useful parameters to look at.
The width can be measured between the phosphorus atoms or C4’ atoms, the latter
usually yielding better results. Since the phosphate groups being closest together are
usually separated by several nucleotides in sequence, the assignment is not always
unambiguous. The Curves algorithm solves the problem by projecting the minor
groove width on the global helix.
In Table 1 we report some standard parameters of canonical A and B-DNA.[35]
Chapter 2
Methods
2.1 Classical Molecular Dynamics
Until 1995, Classical Molecular Dynamics (MD) simulation of nucleic acids were
plagued by instabilities due to approximation methods in the treatment of long range
electrostatics and limited accuracy in the force-field [36]. Thanks to the effort made
by several research groups, stable multi-ns simulations of oligonucleotides are now
possible [3, 37, 38, 39]. It has long been known that a correct treatment of long range
electrostatic interactions is crucial in highly charged polyelectrolytes and approximate
truncation methods lead inevitably to severe defects in the simulation, such as local
heating, distortion of the double helix and complete rupture of Watson-Crick base-
pairs [40]. Increasing computational power allows now for a more rigorous treatment
of electrostatics, using faster algorithms such as the particle mesh Ewald method.
Together with more accurate force fields, simulations of nucleic acids are possible
without imposing artificial structural constraints and these simulations provide useful
insight into the dynamical behavior of nucleic acids.
Here, we describe shortly the force-field used here, the integration method of the
equations of motion (EOM) and the Ewald summation method.
2.1.1 Force Field
The classical Force Field describes the structure and covalent connectivity of molecules.
For large biological systems, typically a pairwise additive potential function is used,
which takes the form:
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U =
∑
bonds
kb(r − req)2 +
∑
angles
kθ(θ − θeq)2 +
∑
dihedrals
∑
n
Vn
2
× [1 + cos(nφ− γ)]
(2.1)
+
∑
i
∑
j>i
[(
Aij
r12ij
− Bij
r6ij
) +
qiqj
·rij ] + Λ
where req and θeq refer to equilibrium bond lenghts and angles, kb and kθ are the
vibrational constants and Vn is the torsional barrier corresponding to the nth barrier of
a given torsional angle with phase γ. The last two terms in equation (1) refer to non-
bonded interactions described by a Lennard-Jones potential, containing an attractive
term due to dispersion (1/r6) and a repulsive term due to exchange repulsion (1/r12)
and an electrostatic interaction term, where  is the dielectric constant.
The bond and angle parameters can be quite easily derived from ab initio cal-
culations of small fragments in vacuo. The derivation of the torsional parameters
especially in case of the floppy sugar-phosphate backbone is a delicate task. In this
work I use the modified Cornell et al. force field (parm98) [41]. Cheatham et al.
introduced some subtle modifications in the Cornell et al force field in order to bet-
ter reproduce the equilibrium between C2’-endo and C3’-endo sugar puckers and the
helical repeat for DNA, which is slightly underestimated by the parm94 force-field
[42]. The changes are shown in Table 2.1 The changes do not lead to a systematic
improvement over the original force field. One drawback for example is the slower
conversion from A to B-DNA or vice-versa, which could hamper effective sampling
in short MD runs.
2.1.2 Integration of equation of motion
During the molecular dynamics simulations, the system evolves according to the clas-
sical equation of motion, which can be expressed by the Lagrangian as follows:
d
dt
(∂L/∂q˙k)− (∂L/∂qk) = 0 (2.2)
where L = K − V with K = 1
2
mq˙2k and V is given by the force field as defined above.
qk are generalized coordinates and q˙k the corresponding velocities. From equation 2.2
Newtons equation of motion for the nuclei can be derived:
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n Cornell et al. Vn γ(◦) parm98.dat Vn γ(◦)
[kcal/mol] [kcal/mol]
CT-OS-CT-N* 3 1.15/3 0.0 0.383 0.0
CT-OS-CT-N* 2 0.0 0.0 1.0 0.0
OS-CT-CT-OS 3 0.144 0.0 0.144 0.0
OS-CT-CT-OS 2 1.0 0.0 1.5 0.0
OH-CT-CT-OS 3 0.144 0.0 0.144 0.0
OH-CT-CT-OS 2 1.0 0.0 1.5 0.0
OH-CT-CT-OH 3 0.144 0.0 0.144 0.0
OH-CT-CT-OH 2 1.0 0.0 1.5 0.0
OS-CT-N*-CK 2 0.5 180.0 0.0 0.0
OS-CT-N*-CK 1 2.5 0.0 2.5 0.0
OS-CT-N*-CM 2 0.5 180.0 0.0 0.0
OS-CT-N*-CM 1 2.5 0.0 2.5 0.0
Table 2.1: Changes in the Cornell et al. force field introduced by Cheatham et al. [42].
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Fk = −∂E
∂qk
= Mq¨k (2.3)
Computing the classical trajectory exactly would require to solve a system of 3N
second order differential equations, where N is the number of atoms.
In practice, these equations are never solved exactly but rather approximated by a
suitable algorithm. To this aim, the positions, of each coordinate are expressed by a
Taylor expansion in r(t). Suitable combination of these expansions yield an expres-
sion for r(t + δt) and in a similar way, one obtains expressions for v(t + δt) and
a(t + δt).
The most widely used algorithm is the Verlet algorithm, which uses the positions at
time t and time t− δt as well as the acceleration at time t to estimate the positions at
time t + δt:
r(t+ ∆t) = 2r(t)− r(t−∆t) + F (t)
m
∆t2 +O(∆t4) (2.4)
In this original algorithm the velocities do not appear explicitly, which inhibits tem-
perature control by velocity scaling. The leap-frog algorithm, which is equivalent
to the Verlet algorithm, updates both positions and velocities using the forces F(t)
determined by the positions at time t:
v(t+
∆t
2
) = v(t− ∆t
2
) +
F (t)
m
∆t
(2.5)
r(t+ ∆t) = r(t) + v(t+
∆t
2
)∆t
The precision of the algorithm is up to third order (in the Taylor expansion) and fulfills
the condition of time-reversibility. The ensemble generated by an MD simulation
is NVE. By coupling the system to a thermostat [43, 44, 45], one obtains the NVT
ensemble, and by introducing pressure coupling, one obtains the NPT ensemble. Even
though the Berendsen weak coupling algorithm is extremely efficient for relaxing
the system to the target temperature, it does not allow for sampling of the canonical
ensemble (even though the differences might be negligible). Canonical ensemble
simulation is enabled by employing a Nosé-Hoover thermostat [44, 45].
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2.1.3 Thermostats
Constant temperature can be obtained by coupling the system to a thermostat. Several
methods are usually available in typical MD packages:
• Weak coupling method (Berendsen thermostat) [43].
• Coupling to an external bath (Nosé Hoover thermostat) [44, 45].
In the weak coupling method, the temperature of the system is kept close to the target
equation by the equation:
dT
dt
=
1
τT
[T0 − T (t)] (2.6)
where T is the instantaneous value of the temperature and τT is the temperature cou-
pling time. The instantaneous temperature T of a system withNdf degrees of freedom
is related to the kinetic energy Ekin(t):
Ekin(t) =
N∑
k=1
mkq˙
2
k(t) =
1
2
NdfkbT (t) (2.7)
The atomic velocities can then be scaled by a factor λ as follows:
δEkin(t) = [λ(t)
2 − 1]1
2
NdfkbT (t) (2.8)
The factor λ(t) is used to scale the velocities q˙k at each integration step, in order to
relax the temperature towards the target value T0. The relaxation rate is controlled by
the time coupling constant τT .
In the Nosé-Hoover approach, the ensemble is extended by introducing a thermal
reservoir and a friction term in the equations of motion. The friction force is pro-
portional to the product of each particle’s velocity and a friction parameter ξ. This
friction parameter is a fully dynamic quantity with its own equation of motion. The
time derivative is calculated from the difference between the current kinetic energy
and the reference temperature. Thus, the equation of motion for each particle reads
now:
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d2ri
dt2
=
Fi
mi
− ξ dri
dt
(2.9)
and the equation of motion for the bath parameter ξ becomes:
dξ
dt
=
1
Q
(T − T0) (2.10)
where T0 is the reference temperature and Q determines the strength of coupling to
the heat bath.
2.1.4 Ewald summation
Ewald summation is a technique for computing the interaction of a charge and all its
periodic images [46, 47, 48]. The charge distribution ρ(r) in the system is an infinite
set of point charges, mathematically represented as delta functions:
ρ = qiδ(r − ri) (2.11)
Each point charge qi is now surrounded by an isotropic Gaussian charge distribution
of equal magnitude and opposite sign.
ρGi (r) = −qi(α/
√
pi)3e−α2|r−ri|
2
(2.12)
This smeared charge screens the interaction between the point charges, so that the
interaction calculated using the screened charge distribution becomes short-ranged
due to the appearance of the complementary error function. The smeared electrostatic
interaction energy reads now:
Es =
1
4pi0
1
2
∞∑
n=0
N∑
i=1
N∑
j=1
qiqj
|rij + n|efrc(α|rij + n|) (2.13)
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erfc(x) = 2pi1/2
∫ ∞
x
e−y
2
dy (2.14)
Es can now be well approximated using a finite summation. A purely Gaussian
charge distribution EG must be added in order to recover the original charge dis-
tribution. The interaction of these Gaussian distributions can be calculated as a lattice
sum in reciprocal space as follows:
EG =
1
4pi0
2piL−3
∞∑
k 6=0
k−2e−k
2/(4α2)
N∑
j=1
qje
−k·rj2
(2.15)
− 1
4pi0
pi−1/2α
N∑
j=1
q2j
The parameter α can be tuned in order to optimize convergence properties of both
summations. In particular, in the particle mesh Ewald method, α is chosen suffi-
ciently large so that atom pairs for which rij exceeds a specified cutoff are negligible
in the direct space sum. The reciprocal space sum is then approximated by a mul-
tidimensional piecewise interpolation approach, in which energy and forces can be
expressed as convolutions and can thus be evaluated by the fast Fourier transforms
(FFT).
2.2 Quantum mechanics
Classical mechanics do not allow for studying chemical reactions, since electrons are
not taken explicitly into account. Inclusion of electrons require however a quantum
mechanical description. In quantum chemistry each particle is described by a wave
function Ψ(r, t), where Ψ∗Ψ represents the probability of finding the particle at posi-
tion r at time t. To each classical observable, such as position and momentum, there
exists a corresponding quantum mechanical operator, which when acting on the wave
function, yields the expectation value of this operator. The most important operator,
the Hamiltonian, was introduced by Schrödinger and enables to calculate the energy
of a given system, constituted of M nuclei and N electrons. The Schrödinger equation
in its time-independent form reads:
20 Methods
HΨ = EΨ (2.16)
where the Hamilton operator can be divided into several terms as:
H = T + Vext + Vee (2.17)
T is the kinetic energy operator, Vext is the external potential produced by the nuclei
acting on the electrons and Vee is the electron-electron potential. The precise form
of the Hamilton is obtained by substituting the classical form of observables by their
quantum mechanical operator:
x = xˆ
(2.18)
px =
~
i
∂
∂x
Other variables, such as spin have no classical counterpart but can also be introduced
in the Hamiltonian. Since in this work we are only interested in closed shell system,
we do not need to consider spin variables.
2.2.1 The variational principle
In practice, the wave function of an interacting many-body system is not know a
priori. To solve the Schrödinger equation one starts from a trial wave function ΨT ,
which is usually a linear combination of basis functions:
ΨT =
∑
n
cnψn (2.19)
where ψn are orthonormal and normalized wave functions, such that
∑
n |cn|2 = 1.
An approximation to the true ground-state wave function is found by applying the
variational principle, which states:
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“The expectation value of a Hamiltonian, Hˆ , calculated with a trial wave func-
tion ΨT is never lower in value than the true ground state energy, 0 , value calculated
with the true ground-state wave function Ψ0.
By minimizing 0 with respect to ψn, which means basically optimizing the linear
combination coefficients, one obtains the true ground-state wave function with the
corresponding ground-state energy.
2.2.2 Born-Oppenheimer Approximation
The Born-Oppenheimer Approximation is the assumption that the electronic and nu-
clear motion can be separated. The many-body wave function depends both on elec-
tronic and nuclear degrees of freedom, but since the electrons are by orders of mag-
nitude lighter than the nuclei, they move much faster and relax very rapidly to the
instantaneous ground-state configuration given by the nuclear positions. The nuclei
can therefore be considered as stationary points and their coordinates enter as param-
eters in the wave function for the electrons:
Ψ˜(ri, Rα) = Ψ(ri;Rα)φ(Rα) (2.20)
where ri are the electronic variables and Rα are the nuclear positions. The electronic
wave function can now be reintroduced in the Schrödinger equation for the electrons
for a given nuclear configuration:
[−1
2
∑
i
∇2i −
∑
i
∑
α
Zα
|ri − Rα| +
1
2
∑
i
∑
j 6=i
1
|ri − rj ]Ψ(ri;Rα) = e(Rα)Ψ(ri;Rα)
(2.21)
where e(Rα) is called the adiabatic contribution of the electrons to the energy of the
system. This is usually a very good approximation, since the nuclear and electronic
frequencies are well separated.
2.2.3 Density Functional Theory
Density Functional Theory (DFT) allows to calculate ground-state properties, and in
its extension also excited state properties, from the electron density of an N-electron
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system. As a result of the Born-Oppenheimer approximation, the Coulomb potential
arising from the nuclei is treated as a static external potential Vext:
Vext = −
∑
α
Zα
|r − Rα| (2.22)
The remainder of the electronic Hamiltonian includes the kinetic part and the electron-
electron interaction:
Fˆ = −1
2
∑
i
∇2i +
1
2
∑
i
∑
j 6=i
1
|ri − rj| (2.23)
The ground-state Ψ(ri;Rα) for this Hamiltonian gives rise to a ground-state electronic
density ρ0(ri):
ρ0 =
∫
Ψ∗0Ψ0dr (2.24)
Both the ground-state wave function and density are functionals of the number of
electrons N and the external potential Vext(R). Density Functional Theory is based
on two theorems proposed by Hohenberg, Kohn and Sham in the early 60’s [49, 50].
• The external potential Vext is uniquely determined by the corresponding ground-
state electronic density, to within an additive constant. The opposite is true as
well: the external potential Vext determines exactly the electron density ρ(~r).
Furthermore, the ground state expectation value of any observable is a unique
functional of the ground state density.
• The variational principle is also valid for the electron density. The total energy
is minimal for the ground-state density ρ0(~r) of the system.
The Schrödinger equation can now be reformulated by using the density ρ:
E[ρ] = Fˆ [ρ] +
∫
drVext(r)ρ(r) (2.25)
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Fˆ is a universal functional of ρ and the ground-state density is found by minimizing
the functionalE[ρ] with respect to ρ. DFT would in principle be exact if the functional
would be known exactly. This is however not the case. Kohn and Sham separated Fˆ
into three distinct parts as follows:
E[ρ(r)] = Tsρ(r) +
1
2
∫ ∫
ρrρr′
|ri − ri′ |drdr
′ + Exc[ρr] +
∫
ρ(r)Vext(r)dr (2.26)
The kinetic energy term and the exchange-correlation functional are not solvable in
this form. The former can however be calculated if the electron density ρ(r) is build
up from wavefunctions Ψi(~r) which are then used to calculate the kinetic energy Ts
Ts[ρ(r)] =
1
2
N∑
1
∫
Ψ∗i (r)∇2Ψidr (2.27)
Kohn and Sham proposed a coupled set of differential equations, the Kohn-Sham
equations:
[∇2 + VH + Vxc + Vext]Ψi(~r) = iΨi(~r) (2.28)
where VH is the Hartree potential, Vxc the exchange-correlation term, Vext the external
potential and Ψi(~r) are the Kohn-Sham orbitals. These equations are then solved
iteratively until self consistency is attained.
The exchange correlation potential Vxc follows from equation 2.29:
Vxc =
δExc[ρ(r)]
δρ(r)
(2.29)
This potential, since not known exactly, has to be approximated. The most common
functionals are:
• Local Density Approximation (LDA)[51]: the exchange-correlation energy at
point ~r is approximated by the exact exchage-correlation energy of a homoge-
neous electron gas with density ρ[r]:
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ELDAxc [ρ(r)] =
∫
(r)[ρ(r)]ρ(r)dr (2.30)
The LDA method is often surprisingly accurate and gives generally very good
results for systems with slowly varying charge densities.
• General Gradient Corrected methods (GGA): take also the first gradient of the
density into account:
EGGAxc [ρ(r)] =
∫
(r)[ρ(r)]ρ(r)dr +
∫
Fxc[ρ(r), |∇ρ(r)|]dr (2.31)
where Fxc is a suitable functional, which satisfies certain known limits of Exc.
One of the most popular gradient corrected functionals is given by the combination
of the Becke exchange functional and the Lee, Yang and Parr correlation functional
(BLYP) [52, 53]. The Becke exchange functional is given by:
Ex[ρ] = E
LDA
x [ρ]− β
∫
ρ4/3(r)
x2
1 + 6βsinh−1x
dr
with (2.32)
x =
|∇ρ(r)|
ρ4/3(r)
The parameter β is determined by a fit on the exact HF data and was fixed by Becke
to be 0.0042au.
The Lee, Yang and Parr correlation function was derived from the Colle-Salvetti for-
mula to calculate the correlation energies from HF second order density matrix:
Ec[ρ] = −a
∫
1
1+dρ1/3
(ρ + bρ−2/3[CFρ
5/3 − 2tW + (19tW + 118∇2ρ)]e−cρ
1/3
)dr
where (2.33)
CF =
3
10
(3pi2)2/3, tW (r) =
1
8
|∇ρ(r)|2
ρ(r)
− 1
8
∇2ρ(r),
a = 0.04918, b = 0.132
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One drawback of the BLYP functional is its poor description of long-and medium
range exchange-correlation effects. A further improvement is achieved with hybrid
functionals, such as B3LYP where some of the exact HF exchange is added:
Exc = a0E
HF
x + (1− a0)ELDAx + ax∆EBx + (1− ac)EV WNc + ac∆ECLY P (2.34)
where the parameters a0, ax and ac are fitted to thermodynamic and spectroscopic
properties of various systems and take the typical values of 0.20, 0.72 and 0.81 re-
spectively.
In this work we use mainly the BLYP functional, which has shown to give in general
very good results for biological systems [54, 55, 56].
2.2.4 Car-Parrinello Molecular dynamics
In the 80’s Car and Parrinello developed a method, which combines molecular dy-
namics and density functional theory [57]. The electronic and nuclear degrees of
freedom evolve simultaneously according to a modified set of classical equations of
motion, in which a fictitious electron mass is assigned to the electronic Kohn-Sham
(KS) orbitals Ψi. Forces are evaluated both on the nuclei and the electrons applying
the Kohn-Sham equations. The Lagrangian of the combined system reads then:
LCP =
1
2
N∑
i
µi|Ψ˙i(r)|2dr+1
2
∑
α
MαR˙
2
α−EKS[(Ψi), (Rα)]+
∑
ij
λij(Ψ
∗
i (r)Ψj(r))−δij
(2.35)
where µ is the fictitious electron mass, Mα and Rα refer to the nuclar mass and coor-
dinates and the Lagrangian multipliers δij ensure the orthonormality between the KS
orbitals. The forces are given by the Euler equation:
µΨ¨i(r) = −HKSΨi(r) +
∑
j
λijΨj(r)
(2.36)
MαR¨α = −δE[(ψi), (Rα)]
δRα
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The effect of the nuclei on the electrons is included in the Kohn-Sham Hamiltonian
HKS, whereas the nuclear motion depend also on the electron degree of freedom
through E[(ψi), (Rα)]. The Kohn-Sham energy is conserved during the dynamics as
long as adiabaticity is ensured. This is the case when the two frequency spectra are
well separated. The lowest electronic frequency is estimated by the electron gap Egap
between the highest occupied and lowest unoccupied Kohn-Sham orbital.
ω = (2
EGAP
µ
)1/2 (2.37)
and thus adiabaticity can be controlled by chosing an appropriate fictitious electron
mass. Furthermore, chosing a small integration time step for the equations of motion
assures that the electronic wavefunction stays close to the Born-Oppenheimer surface.
The integration of the equation of motion is done by the Verlet algorithm.
2.2.5 Plane waves & Pseudopotentials
A particular convenient implementation to solve the Schrödinger equation in periodic
system is to use planewaves:
Ψnk(r) = exp(ik · r)unk(r) (2.38)
unk is a strictly cell periodic function, such that unk(r + R) = unk(r) and k denotes
a good quantum number, related to translational symmetry. A periodic function can
however always be expressed as a Fourier series:
u(r) =
∑
G
u˜G exp(iG · r) (2.39)
Equation [2.39] can be reintroduced in [2.38], which then reads:
Ψnk(r) =
∑
G
cnk(G) exp(i(k +G) · r) (2.40)
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Applying Bloch’s theorem one can show that one needs only to sample k-vectors
lying within the first Brioullin zone. For each k-vector in the first Brioullin zone,
one must calculate the occupied eigenstates of the Hamiltonian in order to construct
the density. However, the wave-functions and other properties such as Hamiltonian
eigenvalues vary smoothly over the Brillouin zone [58] so that in practice only a finite
set of points need to be chosen, and methods for making efficient choices have been
developed [59, 60, 61].
The volume of the Brioullin-zone is related to the volume of the supercell as follows:
ΩBZ =
(2pi)3
Ωcell
(2.41)
In very large systems, the Brillouin zone volume is very small and only a few k-points
need to be considered to describe the variation across the Brillouin zone accurately. In
this work we therefore only calculate the wave-functions at the centre of the Brillouin
zone, k = 0, known as the Γ-point. This has the added advantage that at this k-point
the wave-functions can be chosen to be real without loss of generality.
A further approximation is based on the observation that core electrons are rather un-
affected by changes in their chemical environment. We therefore consider only the
valence electrons during the dynamics and the effect of the core electrons is consid-
ered to be constant and will be included in a pseudopotential. One can construct now
much smoother wavefunctions, ψPS , since the rapid oscillations close to the nuclei,
which assure orthogonality between core and valence states are no longer needed.
This has the advantage that the number of planewaves in the expansion of the wave-
function can be greatly reduced. The new pseudo-valence states are constructed from
an all-electron calculation:
[Hˆ + VˆPS]|ψPS〉 = E|ψPS〉
(2.42)
VˆPS =
core∑
n
(E − En)|χn〉〈χn|
where χ are the core-electron states and En are the energy eigenvalues of these states.
The pseuodpotentials should be transferable, which means that they must reproduce
the effect of the core electrons in different molecular environments. Further condi-
tions have to be fullfilled:
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• The lowest pseudo wavefunction generated by the pseudopotential should not
contain any nodes.
• The normalised atomic radial pseudowavefunction with an angular momentum
l should be equal to the normalised radial all electron wavefunction outside a
given cut-off radius rcl:
RPPi (r) = R
AE
i for r > rcl (2.43)
• Norm conservation: The charge inside of rcl has to be the same for both wave-
functions:
∫ rcl
0
|RPPl (R)|2r2dr =
∫ rcl
0
|RAEl (r)|2r2dr (2.44)
• The eigenvalues of both wavefunctions should be the same:
PPl = 
AE
l (2.45)
2.2.6 Wannier Centers and Boys orbitals
Chemical concepts are often visually depicted in terms of localized orbitals. Boy’s or-
bitals are a useful tool to characterize chemical bonds as well as lone pairs. In a plane
waves approach, a generalization of Boys orbitals is introduced to map the electronic
density into highly localized molecular orbitals. The maximally localized Wannier
functions are derived by an unitary transformation from the KS wavefunctions. The
positions of the WC centers allow an accurate description of polarization effects in
the simulated system.
According to Marzari and Vanderbilt [62], the Wannier functions are defined as:
wn(r) = unk0(r) =
∑
g
ck0i (g)e
−ig·r (2.46)
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Figure 2.1: Schematic diagram of the relationship between all-electron and pseudo- poten-
tials and wave-functions.
30 Methods
And they are obtained by a unitary transformation:
unk =
∑
k
Ukmnumk (2.47)
under the constraint to minimize the spread function Ω:
Ω =
∑
n
(〈r2〉n − 〈r〉2n) (2.48)
The Wannier Centers correspond to the location of maximal charge density of the
Boys orbitals and can be used to vizualize the polarization of chemical bonds and
lone pairs.
2.2.7 Electrostatic decoupling in clusters
The simulation of isolated clusters within a periodic boundary condition scheme
needs some care, as self-interaction among replicas has to be cancelled. In our calcu-
lations, we have used the procedure developed by Martyna and Tuckerman that allows
treating the system as isolated. This algorithm is based on the general possibility of
writing a potential Φ as the sum of two arbitrary functions:
Φ(r) = φlong(r) + φshort(r)
These functions are defined so that φshort(r) vanishes exponentially quickly at large
distances from the system, while φlong(r) contains all the long-range components of
the physical potential. It can be demonstrated that the average potential energy for a
cluster can be written in the reciprocal space as:
〈Φ〉 = 1
2V
∑
g
|ρ¯(g)|2
[
Φ˜(−g) + φˆscreen(−g)
]
(2.49)
The screen function φˆscreen, defined as:
φˆscreen(−g) = φ¯long(g)− φ˜long(g) (2.50)
is the difference between the Fourier series φ¯long(g) and the Fourier transform
φ˜long(g) of the long-range potential, and its computation in the reciprocal space is
efficient for all g vectors (O (N logN ). . The screen function and has the meaning of
“screening” the interaction of the system with an infinite array of periodic images.
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2.3 QM/MM
Hybrid QM/MM techniques have become very fashionable in the last years [8, 10,
63]. In these schemes the biological system of interest is divided into two parts. The
region of biological interest, typically the active site of a protein or the binding site in
drug-DNA complexes, is treated at the ab-initio level (QM-part) while the remaining
protein or DNA residues as well as the solvent and counter ions are treated classically
(MM-part). A wide variety of schemes have been developed based on Hartree-Fock
(HF), Density functional theory (DFT) or also on the empirical valence bond method
(EVB) [64]. Here we use a method based on DFT and Car-Parrinello molecular
dynamics as implemented in the CPMD program [65] interfaced with the classical
molecular dynamics program GROMOS [66]. Special attention has to be payed on
the way the QM and MM systems are interfaced. The next paragraphs explain how
this is done.
2.3.1 Non-bonded interactions
The interactions can be divided into bonded and non-bonded interactions. The non-
bonded mixed Hamiltonian reads:
Hnon−bonded =
∑
i∈MM
qi
∫
dr
ρ(r)
|r − ri| +
∑
i∈MM,j∈QM
Vvdw(rij) (2.51)
where ri is the position of the MM atom i (with charge qi), ρ is the total charge of the
QM-system and Vvdw(rij) is the van der Waals interaction between the MM-atom i
and the QM-atom j.
The evaluation of the electrostatic interaction causes several problems:
• Positive classical charges deprived of the Pauli repulsion term act as electron
traps when close to the QM-region. This leads to the electron spill-out problem
and this effect is particularly pronounced in highly delocalized wave functions
such as planewaves.
• The full evaluation of the electrostatic interaction is computationally very costly
and of the order NrNMM where Nr is the number of real space grid points.
The first problem is solved by applying a modified classical Coulomb potential [13],
the charge of which is smeared out and goes to a finite value close to the nuclei:
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Figure 2.2: Schematic drawing of modified Coulomb-Potential (black and red) and pure
Coulomb-Potential (blue).
vMM(r) =
rncMM − rn
r
(n+1)
cMM − r(n+1)
(2.52)
vMM is the modified classical Coulomb-potential and rcMM is the covalent radius of
the MM-atom.
The second problem is more intriguing. The computational cost for evaluating
the electrostatic interaction energy is minimized, applying a hierarchical scheme in
which the classical system is divided into three shells around the QM-system:
• In the first shell, closest to the QM-part, the electrostatic interaction energy
is calculated as integral over the QM charge density interacting with the NN
classical point charges in the first shell through the modified Coulomb-potential
described in [2.52]:
Hel =
∑
j∈NN
qj
∫
drρvj(|r − rj|) (2.53)
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• In the second shell, the electrostatic interactions are calculated between the
classical point charges and QM D-RESP point charges, obtained by a fit to
reproduce the electrostatic potential on the NN-atoms [14].
• In the outermost shell, the electrostatic interactions are calculated between a
multipolar expansion of the QM-charge density and the MM classical point
charges contained in this last shell:
Hmp = C
∑
MM
qj
|rj − r¯| +
∑
α
Dα
∑
j∈MM
qj
(rαj − r¯α)
|rj − r¯|3
(2.54)
+
1
2
∑
αβ
Qαβ
∑
j∈MM
qj
(rαj − r¯α)(rβj − r¯β)
|rj − r¯|5
2.3.2 D-RESP charges
In the evaluation of the electrostatic interaction, atomic charges on the QM-atoms are
used in the second shell as described above. These charges are obtained by a fit to
the electrostatic field at the classical atoms close to the QM-region (j ∈ NN ) and
restrained to the corresponding Hirshfeld charges with a quadratic penalty function
[14]. Thus, the charges will reproduce the electrostatic potential due to the QM-
charge density, which is polarized by the MM-part including thus automatically polar-
ization effects. Furthermore, since they are evaluated at every MD-step, fluctuations
during the MD can be monitored easily.
In order to evaluate the electrostatic interactions within the first shell, the potential
at each MM-atom in this part has to be calculated according to equation 2.53 and thus
at each MM-atom the electrostatic potential Vi is given by:
Vi =
∫
drρvj(|r − rj|) (2.55)
The D-RESP charges are then obtained by minimizing the norm of the following
restraining function by a least squares fit:
E =
∑
j∈NN
(
∑
i∈QM
qDi /rij − Vj)2 +W (qDi ) (2.56)
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where W is a restraining function, which makes use of the Hirshfeld charges and is of
the form:
W (qDi ) = wq
∑
j∈QM
(qDj − qHj )2 (2.57)
where wq is an adjustable parameter and the Hirshfeld charges are given by:
qHj =
∫
drρel(r)
ρatj (|r − rj)∑
k ρ
at
k (|r − rk)
− Zj (2.58)
where ρatj is the atomic (pseudo) valence charge density of the atom j and Zj =∫
drρatj (r) is its valence. The Hirshfeld charges provide a physically sound restrain-
ing set, since they are directly related to the charge distribution of the system and
therefore more physical than a restraint to neutral charges.
2.3.3 Bonded Interactions
The bonded interactions consider bonds, angles and dihedrals, which involve atoms
belonging both to the QM and to the MM region. Bond lengths, angle and dihedral
values are taken into account by the classical force-field such that the MM atoms con-
nected to the QM-part adjust themselves according to the classical force-field during
the MD.
The most tricky part is the cut between QM and MM system since the valence shell
of the QM atom, which is part of a mixed QM-MM bond is not saturated. There exist
several ways to remedy this problem, such as the link-atom approach, frozen orbitals
or monovalent pseudopotentials. The QM/MM method used here [13, 14] offers two
possibilities:
• For the last QM-atom a particular monovalent pseudopotential is used, which
has the same mass and charge as the normal pseudopotential but only one va-
lence electron, being able to form one bond towards the QM-system.
• The last QM-atom is saturated by additional hydrogen atoms. These hydrogen
atoms have to be excluded from the classical Hamiltonian, but are however
present in the QM-part.
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entire nucleotide Capping Hydrogens Monovalent Pseudo
C1’
HOMO -4.4402908 -5.2309521 -3.5288509
LUMO -1.3777974 -1.4715600 -2.2638069
GAP 3.0624934 3.7593921 1.265044
C2’/C4’
HOMO -5.36069 -3.74698
LUMO -1.60986 -2.43657
GAP 3.7511 1.31041
Table 2.2: Energies in [eV] for HOMO and LUMO KS-orbitals for Adenosine in water.
Different cutting positions are tested and the electron gap has been monitored.
The first approach is conceptually rather simple and does not introduce unphysical
atoms in the system. It is however difficult to create a transferable pseuodopotential,
which can be used to cut all bond-types. So far, the best results are obtained when
cutting an apolar C-C bond.
The additional hydrogen atoms on the other hand can be introduced wherever needed,
leaving the electronic structure almost unchanged. The interaction with the classical
force-field can be excluded rather straight-forward. The QM-charge density will how-
ever be slightly perturbed due to the presence of additional hydrogen atoms.
We perform several tests both with the monovalent pseudopotential and capping hy-
drogens to see how they influence the electronic structure of nucleic acids. The re-
sults show, that it is difficult to use a monovalent pseudopotential since DNA and
RNA contain almost exclusively polar bonds. In Table 2.2 we report the electronic
gap in the QM/MM system of adenosine in classical water. The adenosine is cut at
different positions both with capping hydrogens and with the monovalent pseudopo-
tential. The latter decreases the electron gap considerably and changes also the nature
of KS-orbitals (Figure 2.3). In particular, the LUMO is centered on the last QM-atom
described by the monovalent pseudopotential, which is clearly an artefact due to the
pseudopotential. Thus, for our purposes, additional hydrogen atoms placed at C1’
are best suited since only a small portion of the nucleoside has to be included in the
system and the electronic structure is well reproduced.
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Figure 2.3: Isodensity surfaces of HOMO (red) and LUMO (blue) for different QM/MM
systems (only QM-part shown). a) entire nucleoside is included in the QM-part. b) Cap-
ping hydrogens in C1’ position. c) Cut with monovalent pseudopotential in C1’-position. d)
Capping hydrogens in C4’ and C2’ position. e) cut at C4’ and C2’.
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2.4 Calculation of chemical shift
Progress in the field of quantum chemistry has made possible caluclations of useful
accuracy and reliability on fragments of biomolecules and transition state metal com-
plexes, containing dozens of atoms. Here, a brief explanation of the chemical shift is
given, followed by a short outline of the method used to calculate 195Pt chemical shift,
i.e. the zeroth order approximation (ZORA) as implemented in the ADF code[67].
2.4.1 Origin of chemical shift
NMR active nuclei have a non-zero spin I, which can take 2I+1 orientations. In
an external magnetic field the degeneracy of these orientations is lifted due to the
splitting of the energy levels. For I=1/2 the energy splitting is:
∆E =
ghB
2pi
(2.59)
where g is the gyromagnetic ratio, an intrinsic constant of every nuclei, and h is
the Planck constant. B is the magnetic field at the nuclei.
The effective magnetic field at the nucleus is not equal to the applied magnetic field
since the latter is shielded by the electrons moving around the nucleus. The resulting
effective field is:
~Beff = ~Bext(1− ~σ) (2.60)
where ~σ is the nuclear shielding tensor, which in the isotropic case simplifies to
the isotropic shielding constant Tr~σ/3. The shielding tensor depends on the chemical
environment of the nucleus. Nuclei of the same kind placed in a different chemical
context are shielded differently and can therefore be distinguished. The chemical shift
is then defined as:
δ/ppm = 106
vL − vref
vref
(2.61)
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where vL is the Larmor frequency of the sample and vref is the Larmor frequency
of a reference compound. The Larmor frequency is related to the shielding constant
as follows:
vL = (1− σ)g ·B
eff
2pi
(2.62)
The shielding constant can be calculated from the mixed second-order derivative
of the energy with respect to the nuclear magnetic moment and the external field
assuming that in lowest order the energy of the system is linear to both ~Bext and µ:
σst =
∂2E
∂Bexts ∂µt
| ~Bext=~µ=0 (2.63)
The calculation of the shielding constant requires an accurate description of the
wavefunction close to the nuclei. In case of heavy nuclei such as Pt, a relativistic
treatment of the electrons is necessary to obtain at least qualitatively reasonable re-
sults. In this work we used the zero-order regular approximation as implemented in
the ADF code [67, 68, 69] in order to treat scalar relativistic terms.
2.4.2 The Zero-Order Regular Approximation
A relativistic treatment requires that both space and time coordinates are equivalent.
This is not the case in the Schrödinger equation (SE), in which spacial coordinates
appear as 2nd-order derivative, whereas the time variable as first-order derivative.
Dirac replaced the time-dependent SE by a four dimensional equation:
[cα · p + βmc2] = i∂ψ
∂t
(2.64)
where α and β are 4×4 matrices. In particular, α can be written in terms of 2×2
Pauli matrices and β in terms of a 2×2 unit matrix I.
αx,y,z =
(
0 σx,y,z
σx,y,z 0
)
(2.65)
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β =
(
I 0
0 I
)
(2.66)
where σx,y,z are the Pauli matrices except for a factor 1/2.
The wavefunction, according to the four-dimensional Dirac equation, contains four
components, which can be attributed to two different particles (electrons and positrons)
and two different spins (α and β):
Ψ =


ΨLα
ΨLβ
ΨSα
ΨSβ

 (2.67)
where ΨL and ΨS correspond to the large and the small components of the wavefunc-
tion, and α and β indicate the usual spin. For electrons, the large component reduces
to the solution of the Schrödinger equation where c→ ∞ and the small component
disappears. The small component of the electronic wavefunction corresponds to the
coupling with the positronic states.
In the presence of an electric magnetic field, the Dirac equation is modified as:
[cα · pi + β′mc2 + V ]Ψ = i∂Ψ
∂t
(2.68)
where V=electrostatic potential
and pi is a generalized momentum operator, including the vector potential A:
pi = p + A.
B=∇ ×A and β′ is the same as above but corrected by the free electron rest energy
(mc2).
In the time independent case, the Dirac equation may be written as:
[cα · pi + β′mc2 + V ]Ψ = EΨ (2.69)
which can be factored out (due to the block-matrix nature of α and β)
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c(α · pi)ΨS + VΨL = EΨL (2.70)
c(α · pi)ΨS + (2mc2 + V )ΨS = EΨS (2.71)
Equation 2.71 can be solved for ΨS and then reintroduced in equation 2.70 to
yield:
[
1
2m
(α · pi)K(α · pi) + (−E + V )]ΨL = 0 (2.72)
where K is defined as:
K = (1 +
E − V
2mc2
) (2.73)
Equation 2.72 is then usually expanded around (E − V )/2mc2 to give the first-
order Pauli Hamiltonian. Such an expansion works fine as long as the velocity of
the electrons is everywhere small compared to the speed of light. This condition is
not satisfied close to the nucleus. Thus, in the approach described by van Lenthe
et al.[70, 71] K in equation 2.72 is replaced by K′=E/(2mc2 − V ). This factor is
always much smaller than 1 and can now be expanded in powers of E/(2mc2 −
V ). Keeping only the zero-order term gives the Zero-Order Regular Approximation
(ZORA) Hamiltonian:
[pi
c22m2c2 − V
pi
+ (
c2
2m2c2 − V )
2Zs ·L
r3
+ V ]ΨL = EΨL (2.74)
From the ZORA-Hamiltonian the energy and energy-derivatives can be calculated
to give the isotropic shielding constant.
Chapter 3
Cisplatin
3.1 Introduction
The antitumoral activity of cisplatin (cis-diamminedichloroplatinum(II)) has been for-
tuitosly discovered by Rosenberg in 1969. Nowadays, the drug is widely used in clinic
treatment against a variety of cancer deseases [72, 73, 74, 75]. Its beneficial effects
arise from its binding to DNA nucleobases, preferentially to two N7 atoms belonging
to two adjacent guanine nucleobases or, to a lesser extent, to adenine guanine (AG)
sequences [76, 77, 72, 78, 79]. Other adducts such as G-G interstrand compounds
have also been observed. The binding of cisplatin to DNA is believed to act as a
signal giving rise to a complex cellular response, which in susceptible cells, activates
programmed cell death, i.e. apoptosis. Different adducts have different biological
effects such as mutagenesis [80, 81], inhibition of DNA polymerases [82], and repair
of specific DNA adducts [83, 84]. Based on the hypothesis that the biological effects
of the platinum-DNA adducts are related to specific modifications of the helical DNA
structure, the latter has been extensively studied over the last decades, making use of
different methods, such as X-ray crystallography, NMR spectroscopy, and molecular
dynamics simulation.
All structural studies have shown that cisplatin binding induces an overall curvature
of the DNA double helix towards the major groove [85, 86, 87, 88, 89, 90] associ-
ated to an opening of the minor groove. The platinated DNA moieties bind to the
High Mobility Group (HMG) domains of proteins [91, 92, 93, 94, 95, 96, 97, 98], im-
peding replication and cell repair processes [87, 99], leading eventually to cell death
[100, 87, 101, 102, 103].
The available structures of cisplatin in complex with B-DNA oligomers in the solid
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pdb-entry Experiment/ Sequence Specification Axis bend
Resolution [◦]
or # structures
1A2E X-ray/1.63 5’d(CCTCG*CTCTC) interstrand -
5’-d(GAGAG*CGAGG)
1A84 NMR/1 5’-d(CCTCTG*G*TCTCC) intrastrand 84.5
1AIO X-ray/2.6 5’-d(CCUCTG*G*TCTCC) intrastrand 39.7
1AU5 NMR/1 5’-d(CCTG*G*TCC) intrastrand 65.8
1CKT X-ray/2.5 5’-d(CCUCTCTG*- intrastrand 65.7
G*ACCTTCC)
HMG A
1DDP NMR/10 5’-d(GATAG*CTATG) interstrand -
5’-d(CATAG*CTATC)
1I1P Xrau/1.63 5’-d(CCCTCG*CTCTC) interstrand -
5’-(GAGAG*CGAGG)
1KSB NMR/1 5’-d(CTCCG*G*CCT) intrastrand 55.6
5BNA X-ray/2.6 5’-d(CGCG*AATTCG*CG) mono- -
substituted
5’-d(CGCG*AATTCGCG)
Table 3.1: Available structures of cisplatin-DNA compelxes where G* denotes the platinated
site.
state (solved by X-ray diffraction) [91, 86, 88] and in aqueous solution (solved by
NMR) [90, 104, 89, 105] provide detailed information on the mode of binding of
cisplatin but evidences also large differences between the available structures (Table
3.1).
The metal ion, by binding to DNA causes an axis bend of the double helix rang-
ing from 40◦ to 84◦ [85, 90, 104, 86, 89]. Furthermore, the rise is larger at the plati-
nated site, the propeller twist is increased with respect to B-DNA, and in some cases,
some of the Watson-Crick hydrogen bonds are disrupted [89, 90, 88, 106]. The Pt-
coordination geometry is slightly distorted from its typical square planar conforma-
tion: the metal ion moves out of the plane defined by the purine rings (deviation 0.4
to 1.3 Å), with an N7-Pt-N7 angle as small as 69◦ [107].
The DNA double helix around the platinated site is distorted in a way that renders it
more A-DNA like: (i) The minor groove is wider and shallower, (ii) the helix twist
is remarkably lower than in standard B-DNA, leading to an unwinding of the double
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Figure 3.1: Superpostion of NMR (blue) and X-ray structure (red) of the same adduct
helix, and (iii) the sugar moiety in 5’-position of the platinated guanine is in C3’-endo
conformation.
A comparison between the X-ray [85] and NMR [90] structures of cispt-d(CCTC-
TG*G*TCTCC)-d(GGAGACCAGAGG) (A, Figure 3.1) has allowed to pinpoint the
structural differences on passing from the solid state to aqueous solution, namely:
• An increase of the axis bend and roll angle.
• A smaller displacement of the Pt atom from the guanine purine rings.
• A different puckering of the 3’-sugar at the platinated lesion with a 3’-endo con-
formation in the X-ray structure similar to A-DNA and a 2’-endo conformation
in solution.
The structural basis of the molecular recognition between the protein domain and
the platinated DNA has been provided by Lippard and coworkers, who solved the X-
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Figure 3.2: left: cisplatin-DNA adduct (16-mer) in complex with HMG A domain of HMG1
protein. right: Detail view of cisplatin-moiety with PHE37 and SER41 interacting with gua-
nine 8 and 9 and adenine 10.
ray structure of a platinated 16-mer, cispt-d(CCUCTCTG*G*ACCTTCC)-d(GGAGA-
GACCTGGAAGG) in complex with HMG A (B, Figure 3.2) [91].
The HMG domain contains three helixes connected by loop regions of variable
lengths. The X-ray structure of the ternary cisplatin-DNA/HMG A complex shows
that the hydrophobic side-chains of Helix I and Helix II function as a hydrophobic
wedge, which interacts with the minor groove of the DNA (Figure 3.3). Comparison
between NMR-structure of the protein alone and the X-ray structure of the protein
in complex with the cisplatin-DNA adduct, yields an rmsd of 2.1 Å, indicating only
slight structural rearrangement of the protein upon DNA-binding. One of these re-
arrangments involves a positional shift of Phe37 enabling its side-chain to interca-
late between the platinated base-pairs, nameley the G8-C25/G9-C24 base-pair step.
Another key structural determinant for molecular recognition is a hydrogen bond be-
tween SER41 and the N3 atom of A10, the base directly adjacent to the cisplatin-DNA
cross-link (Figure 3.2). Comparison between the X-ray structure of the protein-cispt-
DNA complex and the uncomplexed cisplatin-DNA adduct reveal that the character-
istic structural distortions are conserved, but augmented in magnitude: (i) the overall
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Figure 3.3: HMG A protein in complex with cisplatin modified DNA, showing interactions
between Helix I and Helix II with DNA minor groove. Arginine residues are displaced in ball
and stick and the solvent accessible surface of DNA is shown with electrostatic color-code
such as to evidence interactions between sugar-phosphate backbone and the arginine residues
of the N-terminal and Helix III.
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curvature is as large as 61◦ with respect to 40◦ in the free cispt-DNA adduct. (i) The
roll angle and rise between the platinated guanines are even larger than in platinated
DNA oligomers. In complex with HMG, the hydrophobic DNA-surface is shielded
against the solvent by the intercalated Phenylalanine side-chain, which forms pi − pi
stacking to G9 and edge to face interactions with G8 (Figure 3.2). (iii) The minor
groove is even wider and shallower than in the free cisplatin-DNA adduct and the
helical twist is as low as 9◦ at the platinated site.
Force field based molecular dynamics simulation have provided complementary
information on the dynamics and flexibility of cisplatin and other Pt-based drug-
DNA complexes [108, 109, 110]. In particular, they have shown that platinated DNA
structures are highly flexible, with large fluctuations in the axis bend and curvature
of the DNA double helix. On the other hand, the Watson-Crick H-bond pattern is
completely maintained [111, 112, 113, 108]. Due to the very specialized character
of cisplatin-DNA parameters, the transferability of the force field models is limited
[114, 112]. For instance, the intrinsic dependence of platinum coordination on the
electronic structure requires a special set of torsional parameters to be introduced in
the force field (Figure 3.4) [111]. As a result, force field parameters are available for
very few Pt-based ligands [110, 112, 115].
Here, we present hybrid QM/MM simulations studies on cisplatin/DNA com-
plexes using the approach presented in references [13, 14]. The platinum moiety
is treated at the density functional level, with the Car-Parrinello approach [65], which
has proven to reliably describe structure, dynamics and electronic properties of platinum-
nucleotide complexes in the solid state as well as in water solution [116, 117]. The
remaining DNA residues, solvent molecules and Na+ counter ions are treated clas-
sically and therefore, the steric and electrostatic effects of the surrounding are taken
explicitly into account.
Our calculations are based either on the X-ray structures of platinated DNA alone
(A [85]), or in complex with the HMG A domain of HMG1 protein (B [91]) and
on a canonical B-DNA structure, where we docked manually cisplatin on the GG site
(C). All structures are shown in Figure 3.5.
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Figure 3.4: Additional improper dihedral angles shown in red dashed lines, which are used to
reproduce the Pt-coordination geometry in case of a Pt-Purine bindig: Pt-C5-C2-N7 (k2/2 =
4.7kcal/mol), Pt-C5-C2-C8 (kd/2 = 4.7kcal/mol), Pt-C8-C5-C4 (kd/2 = 30.4kcal/mol),
and Pt-C8-C6-C5 (kd/2 = 27.7kcal/mol).
Figure 3.5: Initial QM/MM structures. left: Complex A, middle: Complex B , right: Com-
plex C
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Complex A Complex B Complex C
Number of atoms 12,280 29,535 12,349
Number of waters 3,877 9,103 3,904
Number of counter ions 20 20 22
x y z x y z x y z
Box size [Å] 59.7 45.0 43.4 67.0 72.0 61.8 63.0 44.8 44.2
Table 3.2: System Sizes of the three classical simulations at the end of equilibration.
3.2 Computational Methods
3.2.1 Structural Models and classical equilibration
The calculations are based on the following three structures:
1. Complex A: cisplatin-d(CCTCTGGTCTCC) X-ray structure at 2.6 Å resolution
(pdb-entry 1AIO1).
2. Complex B: cisplatin-d(CCUCTCTGGACCTTCC)/HMG1 A domain X-ray struc-
ture at 2.5 Å resolution (pdb-entry 1CKT2). The positions of 71 out of 89
residues of HMG1 structure have been detected. The two histidine residues
(HIS20 and HIS24) present in the structure were assumed to be protonated on
the δ-N atom based on their putative hydrogen-bonding pattern.
3. Complex C: Cisplatin docked onto MD equilibrated d(CCTCTGGTCTCC)-B-
DNA.
Sodium counter ions are added so as to counterbalance the total charge of A-C: the
ions were located in the positions of lowest electrostatic potential, calculated with
the AMBER electrostatic term [118]. The complexes are immersed in a periodic box
filled with water molecules, at a density of 1.0g/cm3. Water molecules with their
oxygen atoms closer than 1.76 (i.e. the van der Waals radii of oxygen) to any atom of
the complex are discarded. The final number of atoms and the sizes of the simulation
boxes are reported in Table 3.2.
All structural models undergo first an equilibration phase via classical MD, car-
ried out with the AMBER6 program package [118]. The AMBER parm98 force
field [42, 41] was adopted for DNA, the HMG A domain and the sodium counter
ions. For [Pt(NH3)2 − d(G∗G∗)]2+ and the guanine bases, the parametrization of
Herman et al., modiefied by Kozelka is used [111, 112], along with a harmonic
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constraint of 5 kcal/(mol·Å2) on all the atomic positions of the cisplatin moiety
[Pt(NH3)
2 − d(pG6∗pG7∗)] and, in B, on the C24, C25 nucleobases and residue
PHE37. The latter constraint turns out to be necessary to avoid unphysical distortions
of these groups. Solvent water molecules are treated with the TIP3P model [119].
Electrostatics are evaluated with the Particle Mesh Ewald (PME) method [47, 48].
A cutoff of 10 Å is used for the van der Waals interactions and the real part of the
electrostatic interactions. A time step of 1 fs is applied. Room temperature simula-
tions are achieved by coupling the systems to a Berendsen thermostat [43]. The initial
structures are relaxed by short steepest descent minimization runs of 1000 steps. 100
ps MD at constant volume are performed during which the system is heated up to
300K. 2 ns of MD at constant pressure (1 Atm) and temperature (300K) is then per-
formed. The final MD structures have an overall rmsd of 3.2Å (A), 1.8Å (B) and 3.0
Å (C0) with gyration radius of 11.5 (A), 10.2 (B) and 11.5 (C0) and final densities
of the system of 1.05, 1.03, 1.02g/cm3, respectively. No significant rearrangement
is observed during the dynamics. In particular, in C0, 13 sugar puckers kept their
C2’-endo conformation whereas the other sugars are in the closely related C1’-exo
conformation.
3.2.2 QM/MM calculations
The final A, B and C MD structures are partitioned into two regions.
• The QM-region, treated at the DFT-level, contains the cisplatin moiety and the
two guanine bases coordinated to it. Furthermore, in complex A and complex
B also the phosphate group of G6 (A) or G8 (B) is included since it forms a
hydrogen bond to the NH3 group and is therefore fundamental to reproduce the
electronic properties in the QM-region (Figure 3.6).
• The MM-region consists of the remaining nucleobases, the protein in case of
complex B, the solvent and counter ions and is described by the modified Cor-
nell et al. force field parm98 [41, 42].
The QM-part is cut at C1’ and when the phosphate group is present also at C3’ and
C5’ and saturated by positionally unrestrained, additional ’capping’ hydrogen atoms
[19].
The plane wave basis set is extended up to an energy cutoff of 70 Ry. Norm con-
serving pseudopotentials of the Martins-Troullier type are used [120]. Integration
of the non-local parts of the pseudopotential is obtained via the Kleinman-Bylander
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Figure 3.6: Schematic drawing of QM-region. Carbon atoms, where capping hydrogens are
introduced are shown in red.
scheme [121] for all the atoms except platinum, for which a Gauss-Hermite numer-
ical integration scheme is used. The gradient corrected Becke exchange functional
and the Lee-Yang-Parr correlation functional (BLYP) were used [52, 53]. Isolated
system conditions [122] are applied. D-RESP charges are calculated at each MD step
as described in ref. [14]. In all complexes, the QM/MM-averaged charges are lower
in absolute value than the values in the parametrization of Herman [111], possibly
because of the presence of the DNA environment (Table 3.3).
The electrostatic interactions between QM and MM atoms are calculated as described
in the Chapter Methods.
For the three systems the MM regions are first relaxed during 1,000 steps of MD,
while keeping the QM part frozen. Then 1,000 steps of simulated annealing are per-
formed on the QM system in order to relax the constraints on the QM-atoms. The
systems are slowly heated up to 300K. A time step of 0.073fs is used. NVT simula-
tions are carried out by coupling the systems to a Nosé-Hoover thermostat [44, 45].
The distance constraints between N(AM1)-O1P(DMP) and N7(G6*)-N7(G7*) are
applied in complex A and B during the heating and released at room temperature.
In Complex C the annealing procedure is repeated several times, decreasing step by
step the distance between Pt and N7 from 2.5Å to a final value of 2.17Å. Then, the
system is heated up while the distance between Pt and N7 atoms is kept fixed. At
300K, the constraints are released. The simulations cover 5ps (A and B) and 7ps (C),
respectively.
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Complex A Complex B Complex C Herman
Pt 0.86 (0.02) 0.91 (0.06) 0.91 (0.08) 0.86
AM1 AM2 AM1 AM2 AM1 AM2 AM1/AM2
N -0.18 (0.02) -0.25 (0.06) -0.20 (0.02) -0.07 (0.03) -0.17 (0.02) -0.16 (0.02) -0.525
H1 0.24 (0.07) 0.20 (0.04) 0.09 (0.1) 0.22 (0.06) 0.20 (0.03) 0.23 (0.05) 0.24
H2 0.22 (0.04) 0.31 (0.04) 0.072 (0.09) 0.10 (0.06) 0.27 (0.03) 0.16 (0.03) 0.24
H3 0.11 (0.06) 0.14 (0.04) 0.25 (0.04) 0.22 (0.04) 0.10 (0.03) 0.19 ( 0.06) 0.24
G6* G7* G8* G9* G6* G7* G6/G7
N1 0.12 (0.02) 0.11 (0.02) 0.08 (0.04) 0.10 (0.02) 0.09 (0.02) 0.10 (0.02) -0.758
H1 0.27 (0.02) 0.30 (0.02) 0.29 (0.03) 0.24 (0.03) 0.24 (0.02) 0.23 (0.02) 0.381
C2 0.14 (0.02) 0.15 (0.02) 0.11 (0.02) 0.12 (0.02) 0.08 (0.02) 0.13 (0.02) 0.939
N2 -0.04 (0.02) -0.03 (0.03) -0.09 (0.05) -0.05 (0.02) -0.07 (0.03) -0.05 (0.03) -0.772
H21 0.21 (0.03) 0.26 (0.02) 0.22 (0.03) 0.23 (0.02) 0.18 (0.02) 0.25 (0.02) 0.369
H22 0.12 (0.03) 0.17 (0.02) 0.16 (0.04) 0.15 (0.03) 0.15 (0.11) 0.04 (0.03) 0.358
N3 -0.24 (0.6) -0.24 (0.07) -0.24 (0.06) -0.18 (0.01) -0.35 (0.06) -0.29 (0.05) -0.682
C4 0.02 (0.02) -0.01 (0.02) -0.07 (0.04) 0.09 (0.02) 0.10 (0.02) 0.04 (0.03) 0.564
C5 -0.07 (0.03) -0.06 (0.02) -0.13 (0.03) 0.03 (0.03) -0.04 (0.02) -0.02 (0.02) -0.682
C6 0.08 (0.01) 0.02 (0.02) 0.03 (0.03) 0.09 (0.02) 0.09 (0.02) 0.05 (0.02) 0.721
N7 -0.35 (0.03) -0.26 (0.03) -0.31 (0.03) -0.19 (0.03) -0.23 (0.02) -0.20 (0.02) -0.660
C8 -0.16 (0.03) -0.11 (0.02) -0.10 (0.02) -0.05 (0.02) -0.08 (0.02) -0.03 (0.02) 0.332
H8 -0.15 (0.04) -0.18 (0.05) -0.02 (0.04) -0.17 (0.06) -0.50 (0.03) -0.13 (0.05) 0.113
N9 0.03 (0.03) 0.04 (0.02) 0.02 (0.04) 0.10 (0.03) 0.04 (0.03) 0.11 (0.04) -0.081
O6 -0.40 (0.04) -0.50 (0.03) -0.43 (0.04) -0.55 (0.07) -0.42 (0.03) -0.50 (0.05) -
O1P -0.47 (0.06) -0.40 (0.09)
O2P -0.58 (0.06) -0.49 (0.06)
Table 3.3: QM/MM-averaged D-RESP charges of QM regions of A-C. Comparison with
RESP charges of ref. [111] is made. Standard deviations in parathesis. Labeling as in Figure
4.4
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Figure 3.7: Model compounds with different types of distortions as observed in the X-ray
structure. Top left: fully optimized cisplatin, Top middle: Pt out-of plane distortion, Top
right: Cl-Pt-Cl angle =77◦, Bottom left: fully optimized cispt-imidazole2 , Bottom right: cispt-
imidazole2 with Pt atom displaced from imidazole ring.
3.2.3 Properties Calculation
The QM/MM trajectories are saved every 50 steps, which corresponds to every 3.6 fs.
The following structural properties are calculated:
• DNA structural parameters such as sugar pucker, axis bending and roll angle
are evaluated using the program Curves [32, 33].
• Radial distribution functions (g(r)), rmsd’s and gyration radii are calculated
using the ptraj module of the AMBER6 package [118].
• Energy levels of HOMO and LUMO are calculated by diagonalization of the
Kohn-Sham states both on the QM regions of complexes A-C and of gas phase
models of cisplatin (Figure 3.7) in different conformations.
• 195Pt chemical shifts are calculated by the ADF code [67, 123, 124]
For the ADF calculations we use a localized, Slater-type basis set, in more de-
tail, a triple zeta basis set with one polarization function (TZP) for Pt and a double
zeta basis set with one polarization function (DZP) for the other atoms along with
the BP approximation [52, 125, 126] of the exchange correlation functional are used.
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Bond Leght [Å] Chemical Angle Chemical Displacement Chemical
shift [◦] shift from ring plane shift
1.9 0 90 0 0 520
1.95 190 88 -3 0.4 494
2.00 404 86 -4 0.8 458
2.05 650 84 -4
2.10 913 82 -5
2.15 1200 80 -6
Table 3.4: 195Pt chemical shifts of cisplatin and [Pt − (NH3)2(C3H4N2)2]2+ in vacuo
[ppm].
The BP functional is known to be more accurate than the BLYP approximation for
the NMR properties, in particular for heavy atoms [69, 127]. Scalar relativistic ef-
fects are taken into account with the zero order regular approximation (ZORA) ap-
proach [123, 68, 69]. Test calculations on cisplatin and [Pt(NH3)2(C3H4N2)2]2+
[cispt − (imidazole2)]2+ (Figure 3.7) are performed to estimate the effect of distor-
tions on the calculated chemical shift. It is found that the latter is very sensitive to
bond lengths but to a lesser extent to a distortion of the angles and out of plane dis-
placement of the metal ion Table 3.4. The 195Pt chemical shift, which are calculated
on selected snapshots of the CPMD/classical MD trajectory, are expected to expe-
rience extremely large variations, because of the fluctuations of the Pt-ligand bond
lengths during the dynamics. Thus, calculations can provide only qualitative results
here. Notice that spin orbit terms [127] account for 10% of the chemical shift, as
shown by test calculations on the cisplatin molecule and cisplatin-guanine complexes
[Pt(NH3)2G2]
2+. Indeed, as already discussed previously [123], the 195Pt chemical
shift is mainly determined by the paramagnetic contribution [124]. Thus, these terms
are not expected to affect significantly the results and they are not included here be-
cause of their large computational cost. The difference between these chemical shifts
and that of cisplatin in water (geometry taken from the MD-averaged structure of Ref.
[116]) are finally calculated.
3.3 Results
QM/MM calculations are carried out with a platinated DNA dodecamer (A, Figure
3.5) and a platinated 16-mer in complex with the HMG domain (B, Figure 3.5), based
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Figure 3.8: Coordination geomerty of cisplatin moiety in complex A. Left: initial structure
(from X-ray) and right: QM/MM structure (average).
on the X-ray structures determined by Lippard and co-workers [85, 90, 91]. The cal-
culations were preceded by 2.0ns classical MD simulations allowing for a relaxation
of the DNA structure, while keeping the cisplatin moiety close to its inital position.
Comparison is made with NMR structural data with 195Pt chemical shifts of cisplatin-
DNA adducts [128, 129] This section is concluded by a docking of the [Pt(NH3)2]2+
moiety on a B-DNA dodecamer (C, Figure 3.5) and subsequent QM/MM simulation.
3.3.1 Complex A
Coordination geometry and electronic structure: The cisplatin moiety is very sim-
ilar to the initial X-ray structure (rmsd: 0.9 Å, Table 3.5). However, the Pt-ligand
distances are slightly longer than in the X-ray or in the NMR-structure, as already
noticed in calculations with this computational setup [116]. The platinum ion, which
is moved out of the square planar coordination plane in the X-ray structure, lies now
in the plane defined by its four ligands (Figure 3.8).
The displacement of the metal ion from the purine ligands is smaller than in the
X-ray structure. It is instead rather similar to that in the NMR structure of the same
molecule in water (Table 3.5). The distortion of the Pt-N7-purine ring angle is known
to be related to the destacking of the G6*G7* bases [90]: a larger roll angle between
the platinated residues allows for a less distorted Pt-coordination geometry [91], fa-
voring in this way complex formation. On the other hand, because of the increased
roll angle, the hydrophobic bases are more solvent exposed than in undistorted B-
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A B C X-ray A X-ray B NMR C
[85] [91] [90]
Platinum coordination geometry
Pt-N7(G6*) 2.06(0.007) 2.02(0.15) 2.07(0.06) 1.91 1.98 1.94
Pt-N7(G7*) 2.03(0.06) 2.00(0.14) 2.07(0.04) 1.90 1.89 1.89
Pt-N(AM1) 2.11(0.06) 2.09(0.15) 2.07(0.02) 1.89 1.98 1.98
Pt-N(AM2) 2.09(0.06) 2.08(0.15) 2.08(0.03) 1.96 1.96 1.92
N7-Pt-N7 86(3) 89(3) 86(3) 100 90 90
AM1-Pt-AM2 89(5) 91(4) 92(3) 92 89 90
N7-Pt-AM1 90(5) 92(5) 89(4) 88 89 90
N7-Pt-AM2 93(5) 88(4) 93(4) 72 92 90
Displacement 0.8(0.1) 0.4(0.1) 0.74(0.1) 1.3 0.48 0.7
of Pt from G6*
Displacement 0.34(0.1) 0.09(0.1) 0.8(0.1) 0.8 0.0 0.64
of Pt from G7*
Table 3.5: Average bond lengths [Å] and angles [◦] at platinum coordination site from
QM/MM simulations compared to experimental values.
DNA. Consistently, in our final QM/MM structure the N7-Pt-N7 angle increases from
77◦ in the X-ray structure to 86◦ (Table 3.7) and the roll angle is 42◦ (Table 3.5).
In order to estimate the effect of these distortions on the electronic structure and
on the energetics, we carry out calculations on model systems, namely cisplatin and
the imidazole containing complex [Pt(NH3)2(C3H4N2)2]2+ in vacuo (Figure 3.7).
Different conformations, with geometries similar to that of the [Pt(NH3)2 − d(G6 ∗
G7∗)]2+ geometry in the X-ray structure, are compared to the fully optimized geome-
tries. The energy of the molecule on passing from the ’out of plane’ conformation, as
observed in the X-ray structure, to the optimized geometry is 8.0 kcal/mol . Such an
energy barrier suggests that the ’out of plane’ conformation found in the X-ray struc-
ture has very low probability. However, environmental effects, which are neglected
in these calculations, could alter significantly this picture. In addition, removal of
this distortion causes an increase of the HOMO-LUMO gap from 2.5 eV to 2.8 eV.
Distortion of the Cl-Pt-Cl angle has a much less significant effect (Table 3.6). In all
conformations, the HOMO is mainly localized on the corresponding metal dxy orbital,
as in the geometry-optimized structure [117] and the LUMO is on the dx2−y2 orbital,
which is to be expected for a d8 diamagnetic square planar complex. The same holds
true for cisplatin-Guanine2 complexes in vacuo (Figure 3.9).
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Figure 3.9: HOMO (right) and LUMO (left) KS-orbitals for cisplatin-Guanine2 complex in
vacuo.
The distortion causes also a slight elongation of the metal-ligand bonds (Table
3.6). The same holds true for a displacement of the Pt atom from the imidazole rings.
The presence of the biomolecular frame modifies the nature of the chemically relevant
orbitals. In the QM region of complex A the HOMO lies in the pi-system of G7*
whereas the LUMO is localized on the phosphate group (Figure 3.10).
The HOMO-1 corresponds to the dxy-orbital, but all the d-levels are clustered
within 1eV and can also be switched during the simulation (Figure 3.11). The dx2−y2
level, on the other hand is shifted to the LUMO+1 level. Reordering of the elec-
tronic energy levels is probably due to the perturbation by O6 of the guanine ligands
(isodensity surfaces are shown in Figure 3.10) and has already been observed in Pt-
nucleotide complexes [116].
The 195Pt NMR chemical shift relative to the cisplatin in vacuo with the average
MD structure is 637 (±353) ppm, as compared to the experimental value of 310ppm
[128] (Table 3.6) [129]. Typical errors in calculated 195Pt chemical shifts for energy-
minimized square planar complexes involving Cl and N ligands range from 30ppm to
160ppm [124]. The larger error found here (over 300ppm) might be at least in part
caused by the fact that the calculations are based on QM/MM snapshots where bond
lengths are highly fluctuating. This in turn dramatically affects the 195PtNMR chem-
ical shifts so that only qualitative agreement with experimental values is obtained.
DNA distortion due to cisplatin binding: As mentioned above, cisplatin binding
to DNA causes not only a distortion in the cisplatin coordination geometry but also
considerable structural changes in the DNA. During the QM/MM simulation, the av-
erage DNA curvature increases to an intermediate value between that in the X-ray
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Figure 3.10: Isodensity surfaces of KS-orbitals of complexes A-C, calculated on a snapshot
during the QM/MM simulation. (A): Left: HOMO (light blue) and LUMO (pink), Right:
HOMO-1 (light blue), LUMO+1 (pink). (B): Left: HOMO (light blue) and LUMO (pink),
Right: HOMO-1. (C): Left: HOMO, Right: LUMO.
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A I II III IV V
Geometry
Pt-Cl/Pt-IMI 2.34 2.35 2.36 2.05 2.05
Pt-N 2.10 2.12 2.10 2.09 2.09
Cl-Pt-Cl/ 96 93 76 88 88
IMI-Pt-IMI
N-Pt-Cl/ 83 82/83 94 96 91
N-Pt-IMI
N-Pt-N 98 96 94 90 90
out of plane 0 29.3 2.8 0.0 0.0
Displacement - - 0.0 0.8
from imidazole
HOMO-LUMO energy gap [eV]
CPMD 2.826 2.478 2.672
ADF 2.667 2.306 2.490 3.42 3.38
B A B C
HOMO-LUMO energy gap [eV]
CPMD 2.4 2.6 3.0
ADF 2.3 2.3 2.3
195Pt NMR chemical shift with respect to cisplatin in vacuo
ADF 637 (353) 534 (243) 532 (140)
Table 3.6: Geometric and electronic properties of A: cisplatin (CPT) and
[Pt(NH3)2(N2C3H4)]
2+ (CPT-IMI). I: CPT, optimized structure, II: CPT with Pt
’out-of-plane’ distortion as in crystal structure, III: CPT with Cl-Pt-Cl set to 77◦, IV:
CPT-IMI optimized structure, V: CPT-IMI, Pt displaced from imidazole ring. B: complexes
A-C
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Figure 3.11: Energy level diagram of KS-orbitals for Complex A (left), Complex B, and
Complex C, calculated on a snapshot during the QM/MM simulation.
structure and that in the NMR-structure (Table 3.7), remaining however far from the
84◦ observed in the solution structure [90]. During the short timescale explored, the
overall axis curvature covers values from 30◦ to 76◦. The measurement of the overall
curvature can be affected by the way the overall axis is defined. It is therefore useful
to consider the local axis bend instead, measured between normal vectors of two adja-
cent base pairs. We see that the curvature originates in a large axis bend at the G6-G7
step. The local axis bend at G6-G7 steps is still close to the one observed in the X-ray
structure, but the flanking residues have now as well an increased axis bend (Figure
3.12). Also in the NMR structure, the curvature is not completely localized at the
platinated base-pair step, but extends over 5 base pair steps. The local axis bend does
not carry any information about the directionality of the curvature. This information
can be obtained when looking at the roll or tilt angle. In our case, the increased axis
bend is mainly due to an increased roll angle. A positive roll corresponds to a bend
towards the major groove, whereas a negative roll indicates a bend towards the minor
groove. Here, the roll angle is positive at the G6-G7 step, and thus the DNA is bent
towards the major groove (Figure 3.13).
The square planar coordination geometry imposed by cisplatin forces the otherwise
stacked guanine bases to open up in a way that leads to a larger roll and rise (Figure
3.13). The latter measures the vertical distance between the two bases. The cisplatin
lesion affects also the opposite strand, in particular the minor groove width and depth
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Figure 3.12: Left: Local Axis bend for the platinated base pair step and the two flanking
base pair steps towards either side of the cisplatin lesion, Right: Helical Twist again for the 5
central base pair steps.
Figure 3.13: Left: Rise for the platinated base step and the two flanking base pair steps
towards either side of the cisplatin lesion, Right: Roll between platinated bases and for the
two adjacent base steps.
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Figure 3.14: Left: Minor groove width, Right: Minor groove depth.
and the helical twist. The minor groove, being now very wide and shallow, resembles
more standard A-DNA (Figure 4.5). The helical twist at the platinated base pair step
is extremely low and thus the double helix highly unwound (Figure 3.12).
The Watson-Crick hydrogen bonds around the platinated site are expected to be per-
turbed due to the large distortion induced by the cisplatin moiety. The G6*-C19,
which is intact in the X-ray structure, breaks and reforms several times. This feature
may be consistent with the NMR data, which indicate that the G6*-C19 base pair
is perturbed, retaining only the G6*(O6)-C19(N4) hydrogen bond [90]. The simula-
tion suggests that also the G7*-C18 base pair is highly flexible and the Watson-Crick
H-bond is broken and reformed several times. This bond is intact in the solution
structure, but distorted in the crystal structure [85]. Since our QM/MM simulation
is too short to obtain converged results, we monitor the presence of H-bonds over a
2ns classical molecular dynamics simulation and compare it to a classical MD of the
free DNA with the same sequence. The Watson-Crick hydrogen bonds are disturbed
in the complexed form as can be seen by the lower occupancy. Propeller twists are
increased with respect to standard B-DNA, having values as high as 30◦ (Table 3.7).
Another important effect of cisplatin binding to DNA regards the conformation of the
sugar-phosphate backbone. Indeed, it is found experimentally, that the ribose moi-
ety of G6 undergoes a repuckering from C2’-endo, typical for B-DNA, to C3’-endo,
which is typical for A-DNA. The QM/MM averaged values of the key backbone tor-
sional angles are reported in Table 3.7. The experimentally observed repuckering
from A-DNA in the solid state to B-DNA in aqueous solution occurs on a time scale
of 200-500ps [4]. Here, as expected, it is not observed during our simulation time.
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A B C X-ray A X-ray B NMR C
[85] [91] [90]
Curvature 51(10) 57(5) 48(8) 40 66 85
sugar pucker G6 C3’-endo C2’-exo C2’-endo C3’-endo C3’-endo C2’-exo
sugar pucker G7 O1’-endo C2’-endo O4’-endo C4’-exo C2’-endo C2’-endo
minor groove 8.3-8.7 11.0-11.7 8.6-9.1 10.8 12.0 12.0
propeller twists
T5-A20 -14 (11) 1 (10) -2 (9) 7 3 30
G6-C19 -34 (13) -6 (10) -18 (10) -24 -1 -7
G7-C18 -16 (11) 5 (9) -12 (11) -16 20 -9
T8-A17 -11 (13) -9 (11) -11 (9) -30 2 -3
torsional angles
G6∗χ -149 (9) -98 (10) -80 (10.5) -147 -108 -109
G6∗δ 82 (8) 91 (9) 132 (11) 91 105 92
G6∗ξ -54 (11) -64 (9) -84 (42) -56 -81 -92
G7∗χ -149 (14) -113 (15) -126 (15) -168 -110 -141
G7∗δ 85 (13) 140 (10) 107 (19) 82 137 136
G7∗ξ -76 (11) -103 (60) -98 (16) -82 -148 -91
Table 3.7: Selected Structural Parameters Describing the DNA structure of QM/MM simu-
lation compared to experimental structures. In case of B, the following substitutions in base-
numbering occur: T5=T7,A20=A26,G6=G8,C19=C25,G7=G9,C18=C24,T8=A10,A17=T23
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A B C NMR struct.
A 0.9/1.8 1.04/- 0.9 / 2.98 1.50/4.20
B 0.8/1.8 1.16/- 1.32/-
C 1.34/2.02 1.47/3.96
Table 3.8: Mutual rmsd’s in [Å] of complexes A-C and in the NMR structure of ref. [90].
The first value refers to the Pt-moiety s shown in Figure 3.6, the second value refers to the
entire double helix. Rmsd between the same structures refer to the inital and final average
QM/MM structure.
The final rmsd of complex A with respect to the initial crystal structure and the
NMR structure is 1.8 Å and 4.0 Å, respectively including all atoms. When consider-
ing only the Pt-moiety the rmsd is 0.9 Å and 1.5 Å for the X-ray structure and NMR
structure, respectively (Table 3.8).
Ligand H-bonding: The AM1-G6 phosphate hydrogen bond (Figure 4.4), present in
the X-ray structure, is first broken and then reformed several times until, after about
3 ps it is definitively lost. This feature may be consistent with the NMR structure
of the complex in solution, which does not exhibit this H-bond [90]. The relatively
weak AM2-O6(G7*) H-bond, present in the X-ray and NMR structure, is instead fully
conserved during the dynamics. The other hydrogen belonging to the two ammonia
ligands form H-bonds with water molecules (treated classically). In the first solva-
tion shell there are on average 2.8 water molecules (Table 3.9). The radial distribution
function between ammonia and water and between Pt and water for the QM/MM sim-
ulation and the classical MD of the same complex are compared in Figure 3.15.
3.3.2 Complex B
Pt-coordination geometry and electronic structure: The initial platinum coordi-
nation geometry, which is less distorted than in the X-ray structure of the platinated
DNA in the free state (Table 3.5), is well maintained. The Pt-atom lies in the square
planar coordination plane in agreement with the X-ray structure. The HOMO lies
mainly in the pi*(G9*) -system as in A and the LUMO lies on the dx2−y2 orbital. The
HOMO-1 is concentrated in the dz2-metal orbital. The latter is destabilized due to
the almost axial position of the O6(G9*) oxygen with respect to the Pt-coordination
plane (Figure 3.10).
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Figure 3.15: Water Radial distribution functions (g(r)) for AM1 (upper panel), AM2 (middle)
and Pt (lower panel) of complex A.
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Figure 3.16: Left: Initial Pt-coordination geometry in the X-ray structure. The hydrogen
bond between the phosphate group of G8 and AM1 is still intact. Right: Final Pt-coordination
geometry. The hydrogen bond between phosphate group and AM1 is not present anymore.
Again, the d-levels are clustered within 1eV (Figure 3.11).
DNA distortion due to cisplatin and protein: The overall axis curvature in the
DNA decreases slightly during the simulation from 66◦ to 57◦. Again, the increased
roll angle at the G8-G9 step, which is 61◦ in agreement with the X-ray structure,
accounts mainly for the overall curvature (Figure 3.13). The rise at the G8*G9*
step is significantly larger than in complex A (7.7 Å) and in fair agreement with the
crystal structure (7.4 Å) (Figure 3.13). Larger destacking of the two bases leads to a
smaller distortion of the Pt-N7 bond [91]: the displacement of the Pt-atom from the
purine planes is smaller than in A. On the other hand, the hydrophobic faces of the
guanine bases are even more solvent exposed than in A. The sugar puckers and the
Watson-Crick H-bond patterns are maintained (Table 3.7, Figure 3.18). In terms of
torsional angles, the structure has B-DNA character except for G8* and C11 which
exhibit A-DNA character (Table 3.7). G8*, binding to Pt in 5’ position has A-DNA
conformation also in the X-ray structure [91], but C11 has B-DNA character in the
X-ray structure. The repuckering could be due to thermal fluctuations. The minor
groove width is similar to the initial X-ray structure (Figure 4.5, Table 3.7).
Ligand Hydrogen Bonding: The hydrogen bond between the phosphate group
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A B C
AM1 2.8 4.3 4.2
AM2 2.3 3.4 3.4
Pt 6.1 8.3 8.8
Table 3.9: Number of water molecules in the first solvation of ammonia (within 3.5 Å) and
Pt /within 5.0Å
of G8* and AM1 is lost at the beginning of the dynamics (Figure 3.16), when the
restraint is released whereas the N(AM1)-O6(G8*) and N(AM2) and O6(G9*) hy-
drogen bonds are maintained. In contrast to A, all three hydrogen atoms of AM1
are able to form hydrogen bonds to the solvent and therefore there are more water
molecules in the first solvation shell than in complex A (Table 3.9). There are more
than three waters in the first solvation shell of AM1. As mentioned in ref. [130], this
feature is due to the presence of mobile water molecules in the first solvation shell,
which are not directly hydrogen bonded to ammonia. AM2 has less water molecules
in its first solvation shell than AM1 since one hydrogen is involved in a hydrogen
bond towards O6 of G9*.
3.3.3 Complex C: Docking of [Pt(NH3)2]2+ on B-DNA
The predictive power of our computational setup is investigated by constructing a
structural model of platinated DNA. The [Pt(NH3)2]2+ moiety is docked onto the
two adjacent guanines of B-DNA with the same sequence as A. The B-DNA structure
in solution is previously equilibrated by 2 ns of classical dynamics C0.
Pt-coordination geometry and electronic structure:
The initial Pt-coordination geometry after docking is highly distorted (Figure 3.17).
The initial N7-Pt-N7 angle is 135◦ and the initial N7-Pt bond lengths are fixed to
2.5Å. The stabilization energy due to relaxation of the system, calculated by compar-
ing the energy of [Pt(NH3)2G2]2+ moiety in its initial and final structure, is as high
as 150kcal/mol. Most of this energy resides in the rather strong coordination bonds
[131]. It is therefore not surprising that the bond-lengths adjust themselves very fast.
At the end of our simulation, the square planar coordination geometry is slightly more
distorted than in A, as shown by the displacement of the Pt atom from the purine ring
planes (Table 3.5). The calculated HOMO and LUMO gap is slightly larger than in
complex A (Figure 3.11). The HOMO has large parts of the density on the pi-system
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Figure 3.17: Pt-coordination geometry in complex C at the beginning (left) and at the end
(right) of our simulation.
of the guanine ligand, whereas the LUMO corresponds to the dx2−y2 as in B. The d-
levels lie just below the HOMO clustered within 1eV. The 195Pt NMR chemical shift
relative to cisplatin is 532 (±116) ppm, also in this case in qualitative agreement with
experiments [128, 129]. The very large standard deviations do not allow establishing
whether the agreement is better here or in complex A.
DNA distortion due cisplatin moiety: The distortion in the DNA structure induced
upon cisplatin binding is less immediate. Still, on the very short time-scale explored,
we observe considerable conformational changes in the DNA double helix. A relax-
ation of the initially strongly distorted N7-Pt-N7 angle forces the two coordinated
guanines to open, which leads to an increase in the roll angle (Table 3.5, Figure 3.13).
The final value is still below the one of A, but the running average shows an increas-
ing trend. Since in DFT dispersion interaction are poorely reproduced, one could
argue that the opening of the two bases is an artefact of DFT. We perform therefore
a short classical molecular dynamics simulation and verify that also in this case, the
two guanines are getting destacked. Both local axis bend and roll angle at the G6-G7
base-step increase with final values of 26◦ and 50◦, respectively.
The increased positive roll at the G6-G7 step leads to a local axis bend, which
translates into an overall curvature in the double helix. The average curvature is 48◦
(±8◦), lower than in the reported NMR structure [90], but in good agreement with A.
The local axis bend and roll angles are shown in Figure 3.13 and 3.12 and propeller
twists are reported in Table 3.7.
The torsional angles and sugar puckering are maintained (Table 3.7).
68 Cisplatin
Figure 3.18: occupancy of Watson-Crick hydrogen bonds around the central 6 base-pairs for
the three simulations A-C.
The AM1 ammonia ligand does not interact with the phosphate group of G6* during
the duration of the QM/MM simulation, the distance between the groups decreases
from 9 to 7 Å, which corresponds to an indirect hydrogen bond, mediated by two wa-
ter molecules. Classical MD simulations have shown several transitions from a direct
phosphate-AM1 hydrogen bond to a water mediated hydrogen bond [108] as observed
when passing from crystal [85] to solution structure [90]. During a very short interval
in the MD-dynamics [108] also the two water mediated hydrogen bond has been ob-
served as in C. A direct hydrogen bond favors however N-conformation of the sugar
in 5’-position of the Pt-lesion, whereas with increasing distance between AM1 and
the phosphate group, S-conformation becomes accessible as well. The Watson-Crick
hydrogen bonds are not disrupted during the simulation, at most, there is a slight
perturbation at the base-pairs adjacent to the Pt-lesion (Figure 3.18). In general, the
structure maintains overall B-DNA character and is less distorted than complex A.
Nevertheless, the final structure is quite similar to complex A with an rmsd of 0.9 Å
including the atoms at the Pt-site, and 3 Å including all atoms (Table 3.7). The main
structural differences include the sugar ring of G6* and the G6*-phosphate group
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Figure 3.19: Left: superposition of platinated moiety of complex A and complex C, Middle:
Superposition of Pt-moiety of complex A with NMR-structure, Right: Superposition of Pt-
moiety of Complex C with NMR-structure.
(Figure 3.19). The latter is located further away from the AM1 ligand than in com-
plex A. The rmsd of complex C with respect to the solution structure is 1.5 Å at the
platinated site and 4.0 Å, including all atoms. Thus the final A and C structures, even
though generated from completely different structures, are in fair agreement with each
other.
Ligand hydration: The hydrogen bond between AM2 and O6 of G7* is present as
in complexes A and B. AM1 solvation properties are similar to that of B (Table 3.9),
given the better solvent accessibility of AM1 with respect to complex A.
3.4 Conclusions
We have presented a mixed quantum/classical simulation of cisplatin binding to DNA
in the free state and in complex with HMG A (Figure 3.2).
In A, the coordination geometry of the cisplatin moiety relaxes considerably during
the QM/MM simulation, which is based on the X-ray structure, suggesting that the
’out-of-plane’ position of the platinum atom is due to crystal packing effects. The
angle spanned by the two purine bases and the platinum increases on average by 10◦
and both roll angle and DNA curvature increase. In consequence, the Pt displacement
from the purine ring planes decreases to 0.8Å and 0.4Å, respectively. These values
are comparable to the solution structure [90]. The orientation of the coordinated gua-
nines still differs from solution structure and compares actually better to the X-ray
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structure. We check the dependency of our final results upon the initial structure by
performing simulation C. In this simulation we start from a highly distorted structure,
where the cisplatin moiety is docked on canonical, straight B-DNA. In spite of the
short time-scale investigated, the docking process causes a rather dramatic change in
the DNA structure: The axis bend, the roll angle and the rise increase towards the
values of A and are still increasing in the end of our simulation. The good agreement
between A and C at the platinated moiety is a strong validation of our model.
A second important point for the reliability of our QM/MM approach is the correct
description of the DNA distortion observed in cisplatin-DNA complexes. Stacking
interactions are not well described in DFT methods and this could lead to a trend to
larger roll angles. We compare therefore our results to a fully classical simulation
starting from the cisplatin docked on canonical B-DNA (C). Local axis bend and roll
angle at the platinated step are in good agreement with the QM/MM structure C and
even slightly larger, showing that the destacking of the two guanine bases is not an
artefact of DFT.
We also attempted to calculate 195Pt chemical shifts. The final results are only in
qualitative agreement with experimental data [128, 129] and the too large errors in
our data do not allow to establish a structural relationship.
In complex B the structure remains very close to the X-ray structure. In this case,
crystal packing effects play probably a less important role and therefore no large con-
formational changes are observed when passing from solid state to solution structure,
showing that the QM/MM method reproduces well the overall structural parameters.
The binding of the HMG A domain leads to a higher axis bend.[89] Still, as in A and
C, the DNA maintains its high flexibility. The DNA adopts a larger rise and roll angle
at the platinated site, leading to a smaller displacement of the Pt atom from the purine
rings. The strain on the Pt-coordination geometry is therefore less than in complex
A. Nevertheless, the two structures compare well, given that the orientation of the
two guanine ligands is the same, which confirms again the correct reproduction of the
Pt-coordination geometry (Figure 3.19).
The sugar repuckering experimentally observed on passing from the solid state [85]
to the solution structure [90] is not seen during the QM/MM simulation because of
the short simulation time. Hydrogen bonding between one of the Pt-ammonia ligands
and a phosphate group is not stable through the entire simulation time. This is con-
sistent with experiment where the same H-bond is lost when passing from solid state
[85] to solution [90]. It has been argued that this hydrogen bond might be important
for stability. Our simulation and other MD simulation suggest that once the complex
is formed, the direct hydrogen bond is in equilibrium with an indirect hydrogen bond
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mediated by water molecules. Still, H-bonding to phosphate groups could be impor-
tant during complex formation.
We conclude that the QM/MM approach described here is a valuable tool for
metal-DNA models, especially if combined with classical molecular dynamics sim-
ulation. It allows for a parameter free treatment of the metal-coordination geometry
within the full DNA-solvent environment treated classically and it can be used in
the future to model the interaction of other platinum-based compounds with DNA
oligomers and DNA nucleobases, for which a valuable force field parametrization
has not yet been developed.
Chapter 4
DNA Alkylation by duocarmycins
4.1 Introduction
Duocarmycins make part of a class of exceptionally potent antitumor-antibiotics and
recently, the first duocarmycin derivative has been introduced into clinical trials [21].
Since their disclosure in the 1990’s [132] and the demonstration that they derive
their biological properties through a sequence selective alkylation of duplex DNA,
extensive efforts have been devoted to defining the fundamental principles underly-
ing the relationships between structure, chemical reactivity, and biological properties.
These molecules, which contain a variable number of substituted aromatic ring sys-
tems (Figure 4.1), bind preferentially to A-tracts, forming a covalent bond with N3
of adenine at the end of an A-tract. The moiety reactive towards DNA consists of
cyclopropyl-indole unit condensed with a pyrrole ring (Ring A, Figure 4.1). The least
substituted carbon atom in the cyclopropyl unit of ring A performs a stereoelectron-
ically controlled addition to adenine at the N3 position [133]. Intriguingly, DNA
acts as a catalyst for the alkylation reaction, increasing kobs by at least five orders of
magnitude relatively to adenine in water kobs depends also strongly on the nature and
extent of the substituents, usually indole rings, which are connected to ring A by an
amide link.
The mode of binding of two derivatives (DSA and DSI, Figure 4.1) to DNA has
been provided by the recent NMR structures of the complexes between these drugs
and d(pGpApCpTpApApTpTpGpApC)- d(pGpTpCpApApTpTpA*pGpTpC)(I) [134,
135]. The drugs are accommodated in the minor groove, forming a covalent bond be-
tween its cyclopropyl unit and the last adenine (indicated by a star) of the so-called
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Figure 4.1: Duocarmycin anticner drugs investigated in this work. For DSA ring A and ring
B are indicated and the numeration scheme is provided. For DSI, the torsional angles around
the vinylogous amide bond are displayed
’A-tract’. The latter contains the A-A, T-T and A-T (but not the T-A steps) and ex-
hibits a conformation other than that of canonical B-DNA [35], such as a narrow
minor groove, highly negative propeller twists and a sizeable curvature of the double
helix [1, 2, 136, 137, 138, 139, 140]. Several specific non-bonded interactions are
formed (Table 4.7, Figure 4.2), which are believed to be responsible for the affin-
ity and the sequence-selectivity of the drugs towards the A-tract with guanine as a
flanking residue s[134]: (i) hydrophobic interactions between ring B and the sugar
hydrogens in the minor groove wall. (ii) A hydrogen-bond between the C2-carbonyl
group and the N2-amino group of G20 [141]. No water molecules are present between
the drugs and DNA [134].
DNA acts as a catalyst for this reaction for most duocarmycin derivatives at phys-
iological pH [142]. In particular DSA (Figure 4.1), which features an indole unit
substituted in 5,6,7 positions by three methoxy groups (ring B), reacts five orders of
magnitude faster with adenine in double stranded DNA than with adenine in aqueous
solution. DSI, in which ring B is not substituted, is less reactive than DSA. The struc-
turally related NBOC-DSA compound, in which ring B is replaced by a tert-butyl
group (Figure 4.1), is 3-4 orders less reactive towards DNA compared to DSA [143].
Understanding the key factors governing duocarmycins’ reactivity is clearly of great
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Figure 4.2: Left: Superposition of DSA-I (blue) with DSI-I (red). The drug is shown in
ball and stick whereas the reactive adenine nucleotide is shown as cylinders. Right: Solvent
accessible surface of DNA double helix with electrostatic color code showing the snug fit of
DSI into the minor groove.
76 DNA Alkylation by duocarmycins
pharmacological interest as it could provide the basis for more active drugs.
Several hypotheses regarding the catalytic effect of DNA on the reactivity of the drug
have been put forward: (i) Hurley et al. have proposed that a conformational change
in the DNA double helix may lead to a more reactive adenine-base [144] at the end
of A-tracts. NMR studies reveal particular junction sites at the 3’-end and 5’-end
of the A-tract [136, 137] and duocarmycins could specifically target these unusual
junctions. Alternatively, duocarmycins by binding to DNA could also trap a partic-
ular, more reactive DNA conformation [145]. (ii) Boger et al have suggested that
the higher reactivity of the cyclopropane ring in DSA relative to DSI is caused by
its larger distortion observed in the NMR structures around the amid link (Table 4.1)
[135, 146]. The distortion is measured by the torsional angles χ1 (C7-C8-N12-C16)
and χ2 (C8-N12-C16-O16) (Figure 4.1) and is believed to decrease the pi-electron
conjugation and ultimately the stability of the cylcopropyl unit (Shape induced ac-
tivity). Density functional calculations on a DSA-model (Figure 4.3 [147] and Table
4.2) in the gas phase appear not to support this proposal, although the effects of the
solvent and of the macromolecule are expected to alter considerably these findings in
vacuo. (iii) A general acid catalysis has also been invoked, in which the drugs are
protonated on the O6 group (Figure 4.1) [148, 149]. This hypothesis is based on the
presence of a highly acidic environment around the DNA double helix [150, 151].
Here we investigate binding and reaction mechanism by performing molecular
simulations of the complexes between the drugs in Figure 1 and the oligonucleotide
I. We start by looking at the mode of binding of the non-covalent complexes, for
which no experimental information is available, by extensive classical MD simula-
tions, in order to study the complex before the alkylation reaction. The drugs have
been considered in their neutral form. We find that the duocarmycins investigated
here induce only minor distortions in the DNA scaffold, which argues against a con-
formational change in DNA responsible for its catalytic activity. Calculations on
the covalent adduct show excellent agreement between calculated and experimental
structure, thus validating the force field used in our classical simulation.
We then turn on to study the DNA alkylation reaction of DSA, DSI and NBOC-
DSA with (I), and for the smallest compound (NBOC-DSA) we also study the corre-
spondent reaction in water (R4 in Figure 4.3), which does not occur at physiological
pH, although it reacts at pH=3, t1/2=177h[133].
The technique of choice for describing these chemical reactions is the hybrid Car-
Parrinello QM/MM molecular dynamics simulation of the three drugs [13]. The ther-
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Figure 4.3: Reactions in aqueous solution investigated in this work. a) Reaction between
NBOC-DSA and adenine (A) either isolated (R4) or embedded in I. b) Selected model re-
actions (R1-R3). The assumed reaction coordinate is shown by an arrow originating in N3
and ointing towards C13. In a) the electronic rearrangement upon alkylation is schematically
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DSA NMR DSI NMR covDSA-I covDSI-I
χ1 22.4(0.7) 14.2(0.6) 14.8(9.4) 15.3(8.7)
χ2 11.0(0.6) 13.5(0.7) 13.4(10.9) 20.5(8.5)
χ3 11.4(1.4) 9.7(1.0) 8.4(12.5) 4.7(11.1)
DSA-I DSI-I NBOC-DSA-I
χ1 20.9 (12.9) 20.2 (12.4) 11.7(11.6)
χ2 14.4(12.1) 16.9(10.6) -2.3(13.2)
χ3 9.0(14.3) 6.6(14.4) -
Table 4.1: Average dihedral angles from covalent drug-I and non-covalent drug-I MD simu-
lations compared to NMR structures [134, 135].Standard deviations are given in parenthesis.
modynamic approach has been used to calculate the activation free energy. This ap-
proach has been shown to successfully describe a variety of chemical [152, 153] and
biochemical reactions [15, 152]. Comparison is also made with reference reactions
R1-R3 between three model compounds in water to get a detailed analysis of the in-
fluence of nucleophile and substituents on the reaction profile (Figure 4.3). The role
of the mechanical and electrostatic fluctuations for the binding and for the reaction
is further explored by classical MD simulations and Poisson-Boltzmann calculations.
We find that the biomolecular frame polarizes the reactants significantly and that the
nature of the condensed rings in the drugs affects largely their intrinisic reactivity.
4.2 Computational Methods
4.2.1 Structural Models for the classical MD
The starting structures of complexes between the oligonucleotide d(pGpApCpTpAp-
ApTpTpGpApC)-d(pGpTpCpApApTpTpA*pGpTpC)(I) and DSA and DSI are based
on the NMR structures of the covalent complexes covDSA-I and covDSI-I, respec-
tively (1DSA [134] and 1DSI [135]). The non-covalent DSA-I and DSI-I are con-
structed by removing the covalent bond, closing the cyclopropyl ring and deprotonat-
ing the C6-O6 group. Close contacts are removed manually. For the non-covalent
NBOC-DSA-I complex, the drug was fitted on DSA-I model and close contacts
were again removed manually. 20 sodium counter-ions are added and the systems
are solvated by 4722(covDSA-I ), 4809(covDSI-I), 4946(DSA-I), 4775(DSI-I) and
5013(NBOC-DSA-I) water molecules. The free DNA 11-mer is constructed with the
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nucgen module of the AMBER program package with the same sequence as in the
drug-I adduct: 5’-d(GpApCpTpApApTpTpGpApC)-3’- 5’(d(GpTpCpApApTpTpAp*GpTpC)-
3’).
20 counter ions are added and the system is solvated with 3903 water molecules.
The following model systems are constructed: (Figure 4.3):
R1: Complex between cyclopropane and ammonia;
R2: Complex between cyclopropyl-indole and ammonia;
R3: Cyclopropyl-indole and adenine;
R4: Complex between NBOC-DSA and adenine.
The four systems are solvated by 853, 1001, 1072 and 2109 water molecules in R1,
R2, R3 and R4, respectively, and equilibrated by MD such as to obtain densities of
1.0 gcm−3. The number of water molecules in the first solvation shell is calculated by
integration of the g(r)’s.
The AMBER-parm98 force field [41, 42] is used for the oligonucleotide along
with the TIP3P [119] model for water and the Aaqvist parametrization of sodium
for the counter ions [154]. In the non-covalent complexes, the parameters of DSA,
DSI and NBOC-DSA are adopted from ref. [134], except for the charges, which
are derived from ESP charges (RESP) as described in the AMBER program package
[118], namely by optimizing the structures at the B3LYP-6-31G* level of theory.
For the tert- butyl group of NBOC-DSA typical AMBER parameters for the methyl
groups are adopted. In the covalent complexes, the charges are recalculated both for
the drugs and the attached nucleobase (A19) by the same scheme as described above.
Those of ammonia and the smaller duocarmycin model of R2 and R3, are taken from
the gaff-database [155], except for the charges, which are calculated as above.
4.2.2 Classical MD calculations
The covalent and non-covalent drug-I adducts are minimized by three runs of steep-
est descent (5000 steps) using the AMBER7 program [118], involving (i) the wa-
ter molecules, (ii) the water and the counter ions, and (iii) the entire systems. The
systems undergo then MD simulation. They are first slowly heated up to 300 K at
constant volume, keeping the drug-I adduct frozen. At 300 K, constant pressure,
constant temperature (NPT) is switched on. A harmonic position constraint on the
drug and DNA is steadily decreased starting from a force constant of 2000 kJ/nm.
Periodic boundary conditions are applied and the electrostatic interactions are calcu-
lated with the particle-mesh Ewald method (PME) [47, 48]. Three separate Nose-
Hover thermostats are applied to the DNA, the drug and the solvent, which assure an
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even temperature distribution throughout the entire system. Constant pressure at 1
atm is controlled through extended-ensemble pressure coupling implemented by the
Parrinello-Rahman method [156]. Bond lengths are constrained using the lincs algo-
rithm and the translational and rotational motion of the center of mass of the drug-I
adduct is removed every 25 steps of molecular dynamics. A timestep of 0.001ps is
used throughout all the classical molecular dynamics simulations described here. 10
ns for covDSA-I, covDSI-I, DSA-I , DSI-I and NBOC-DSA-I and 6 ns for the I
are collected and analyzed by the GROMACS program package[157, 158]. All the
simulations are performed on a Xeon 3.06 GHz dual processors PC.
4.2.3 QM/MM Molecular dynamics
The alkylation reaction is studied by mixed Car-Parrinello-classical molecular dy-
namics simulation using the scheme developed by Rothlisberger and co-workers[13].
In this approach, the systems are divided into two regions. The first region (QM) is
treated within the framework of DFT, as implemented in the program CPMD [65].
Planewaves up to energy cutoff of 70 Ry are used along with pseudopotentials of the
Martins-Trouillers type [120]. The second region (MM) contains the rest of the sys-
tem and is treated with effective potentials described above [41, 42]. The QM-parts
include the drugs and the reactive adenine base (A19)(Figure 4.4). The latter is cut
at the C1’ carbon and the valence shell of this last QM-atom is saturated by two ad-
ditional hydrogen atoms (capping hydrogens) [159]. The QM-parts contain 76(DSA-
I), 64(DSI-I) and 63(NBOC-DSA-I) atoms and are placed in an orthorhombic box
with box lengths of 23.8×14.3×21.2Å3 (DSA-I), 23.8×20.0×15.2 Å3 (DSI-I) and
18.0×14.0×18.9 Å3 (NBOC-DSA-I) respectively. The overall charge of QM-parts
is 0. As a starting point we choose a snapshot of the classical trajectory, in which the
drug-adenine distance is about 3.3Å, and the counter ions are not closer than 5Åto
either the adenine A19 or ring A of the drug.
The systems are quenched in the beginning and then relaxed at 0K. This proce-
dure is repeated several times for the first step along our reaction coordinate, and once
for the subsequent steps. The systems are then heated up to 300 K. At 300K, a Nose
thermostat is applied to keep the system at constant temperature [44]. A time-step of
5au (0.12fs) and a fictitious electron mass of 600 au is used. The BLYP functional
is used for all calculations, which has proven to give accurate results for geome-
tries and energetic features [52, 53]). The QM-part is treated as an isolated system
and electrostatic interactions between periodic images are decoupled by the scheme
of Hockney [122]. The additional hydrogen atoms are excluded from the classical
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Figure 4.4: QM-region for the three QM/MM calculations: (left): DSA with DNA, (middle):
DSI with DNA, (right): NBOC-DSA with DNA. In red: last QM atom C1’, which is saturated
with capping hydrogens
Hamiltonian. The electrostatic interactions between the QM part and the MM part
are treated in a hierarchical scheme as described elsewhere [15, 13]. Thermodynamic
integration techniques [160, 161] are used to calculate the activation free energies of
the reactions. We choose the N3(A19)-C13(drug) distance to be our reaction coordi-
nate. At each step along this reaction coordinate, the system is simulated for 1.5ps,
where 0.5ps is discarded, whereas the final 1.0ps are used for analysis. The force
constant on the distance constraint is monitored and the transition state is localized
upon change of the sign of the force constant. This occurs at a distance of 2.3 Å in the
drug-I adducts. The reaction coordinate is sampled at the following distances: 3.3 Å,
3.0 Å, 2.8 Å, 2.6 Å, 2.4 Å, 2.2 Å and 2.2 Å. In the model systems the location of the
transition state varies from 2.1 Å for (R1) to 2.6 Å for (R2,R3). The free energy of
activation has been calculated by integrating the force constant, f(r) along the reaction
coordinate:
∆F# =
∫
〈f(r)〉dr (4.1)
The free energy of activation can be related to kcat through transition state theory.
kcat(T ) =
kBT
hc0
e−∆G
#/RT (4.2)
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∆G# ∼ ∆F# [162] and under saturation condition the experimental rate, given by:
kobs =
kcat[DNA]
KM + [DNA]
(4.3)
where KM is the Michaelis constant, simplifies to kobs ∼ kcat
4.2.4 QM/MM analysis
Boys Orbital Centers (BC) of the fully localized orbitals [62] are calculated on the fly
during the QM/MM simulations. BC’s are useful to visualize lone pairs and chemical
bonds. Here, the polarization index (PIAB) of a chemical bond AB is defined as:
BC =
−−−−−→
A− BC · cosα
−−−−→
A−B
(4.4)
where cosα is the angle spanned between the two vectors
−−−−−→
A−BC and −−−−→A−B.
PI lower than 0.5 indicates a polarization towards A. A change at the second
decimal can be considered significant. D-RESP charges for selected atoms are also
calculated on the fly as described in reference [14]. In particular, we look at the
D-RESP of the nucleophile-nitrogen. Notice that other D-RESP charges are also
calculated, namely the ones on C9, C13 and O6, but they show no clear trend and are
not discussed further.
4.2.5 QM calculations of model system in vacuo
We extend the study of the DSA-model (Figure 4.3) in vacuo presented in reference
[147] to some larger values of χ1 and χ2. To this aim we optimize the geometry by
quenching the structure while keeping one of the torsional angles fixed. The model
system is placed in a box with box lengths of 18×12.96×11.52Å3 and the electrostatic
interactions between periodic images are decoupled by the scheme of Martyna and
Tuckerman [163]. All the calculations are done with the CPMD program [65] as
described above.
In agreement with reference [147] we do not find significant changes in electronic
and structural properties in the cyclopropyl ring upon changes in the torsional angles.
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(A) [◦] 1 2 3 4 5 6 7 8
χ1 7.0 7.0 7.0 7.0 0.0 10.0 20.0 30.0
χ2 5.0 10.0 20.0 30.0 5.0 5.0 5.0 5.0
(B) ∆ Bond length [Å] ∆ PI
C9-C10 0.007 0.004
C9-C13 0.005 0.001
C10-C13 0.003 0.001
N12-C16 0.007 0.006
N12-C8 0.004 0.004
C8-C7 0.003 0.015
Table 4.2: QM-calculations on N-acetyl-DSA in vacuo (Figure 4.3 c). (A) Conformations
for N-acetyl-DSA [◦]. (B) Maximal changes observed in bond lengths [Å] and PIAB’s for
optimized structures.
4.2.6 Poisson-Boltzman calculations
The non-linear Poisson-Boltzman equation is solved iteratively with the program
DelPhi[164, 165, 166], to calculated the field produced by the DNA scaffold onto
the drugs. The charges of the drug itself are therefore excluded. The outer dielectric
constant of the solvent is set to 80 and the one of DNA to 2. An implicit ionic strength
of 0.15M is added. The average potential is calculated for at least 100 snapshots of
the QM/MM trajectory or classic trajectory.
4.3 Results
Here, we describe the MD structures of the non-covalent complexes between the
oligomer I and DSA, DSI or NBOC-DSA. The structures of the DNA scaffold are
compared with that obtained with an MD simulation of I in the free state. Our com-
putational setup for the MD simulations is established by reference calculations on
the covalent DSA-I and DSI-I adducts, for which the 3D structure has been deter-
mined. Next, we discuss the alkylation reaction of DSA, DSI and NBOC-DSA with
DNA based on our constrained QM/MM simulations. Comparison is also made for
the correspondent reaction with adenine in water for the smallest drug, NBOC-DSA.
Finally, by comparing our results with QM/MM simulations of models of NBOC-
DSA/adenine complexes in water we gain insights on the role of the substituted pyr-
role ring and of the adenine nucleophile for the reaction.
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4.3.1 Classical MD Simulations of the DNA/drug complexes
We focus on aqueous solutions of the complexes between the drugs and I in which
the drugs are either non-covalently bound (DSA-I, DSI-I and NBOC-DSA-I, respec-
tively) or covalently bound (covDSA- I, covDSI-I). The systems are built based on
the NMR structures of the covalent complexes (Figure 4.2). Comparison is also made
with the structure of free 11-mer based on the canonical B-DNA conformation in
water.
Validation of the computational setup
Because the force field for the drug is non-standard (see Methods), we first per-
form MD simulations on the complexes for which structural information is available,
namely covDSA-I and covDSI-I and compare our results against experimental data.
These calculations are also used to obtain insights on the conformational fluctations
of these adducts.
The structures exhibit only small rearrangements from the initial NMR structures.
The rmsd’s of the DNA moiety fluctuates around 1.5-1.7Å after 0.5 ns (Table 4.3),
whereas those of the drugs fluctuate around 1.8Å. The structural determinants of
the simulated and experimental structures are similar: (i) The minor groove width
is similar and smaller than that of canonical B-DNA [134, 135] (Figure 4.5); (ii) the
propeller twists are similar and largely negative at the A-tract (Figure 4.5); (iii) the
overall DNA curvature ranges from 15◦ to 17◦ degrees and is mostly caused by local
axis bends at the end of the A-tract. The largest local axis bend for DSI-I is found at
the T4-A5 step for both MD and NMR structures, whereas that of DSA-I is located at
the T4-A5 step in the MD structure and at the A5-A6 step in the NMR structure (iv);
The twist angles at the T4-A5 step are similar and lower than those of canonical B-
DNA (Figure 4.6); (v) The hydrophobic and H-bond contacts are similar, although in
the NMR- structure, the contact distances are in general shorter (by 0.2 Å, Table 4.7).
This may be the reason for the difference seen for the tilt angle at the alkylation site
(Figure 4.6). The torsional angles around C7-C8- N12-C16 (χ1) and around C8-N12-
C16-O16 (χ2), which measure the degree of distortion of the amide link (Figure 4.1),
are fairly similar with the NMR values. However, the rather small difference seen in
χ1 when passing from DSA to DSI, present in the NMR structure, is not observed in
the MD simulations (Table 4.1).
4.3 Results 85
DNA Drug Correlation
covDSA-DNA 1.7(0.3) 1.8 (0.5) 0.69
covDSI-DNA 1.5(0.2) 1.1(0.3) 0.39
Free DNA I 2.4(0.5) - -
DSA-DNA 1.9(0.4) 2.1(0.6) 0.61
DSI-DNA 2.0(0.5) 2.9(0.8) 0.75
NBOC-DSA-DNA 2.3(0.5) 5.0(1.0) 0.33
Table 4.3: Root mean square deviations for DNA and Drug in [Å], standard deviations in
parenthesis, correlation between the two sets of data are also given
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MD Simulation of the free oligonucleotide (I)
It is well-known that the conformation of A-tracts- containing oligonucleotides in
solution differ from that of B-DNA [167, 136, 2, 137]. Indeed, the rmsd between the
final MD structure of (I and the initial B-DNA structure is as large as 2.5Å, pointing
to the differences between the two conformations. In particular for the A-tract, the
MD structure exhibits: (i) A narrower minor groove, with the narrowest value at the
A6 site (4.5 Å vs 5.7 Å for standard B- DNA [35]). (ii) more negative propeller twists
in the A-tract (-20◦ vs. -11◦ in B-DNA). (iii) Larger local axis bends and roll angles
at the end of the A-tract (Figure 4.7). In B- DNA, both local axis bend and roll angle
are ideally 0◦ [35]. The backbone torsional angles are instead similar to those in
canonical B-DNA [35](data not shown).
4.3 Results 87
2
3
4
5
6
7
8
9
de
gr
ee
s
Free DNA
DSA-DNA
DSI-DNA
NBOC-DSA-DNA
Local Axis bend
0
1
2
3
4
5
6
7
8
9
de
gr
ee
s
A2
-C
3
C3
-T
4
T4
-A
5
A5
-A
6
A6
-T
7
T7
-T
8
T8
-G
9
G9
-A
10
covDSA-DNA
covDSI-DNA
NMR DSA
NMR DSI
0
5
10
15
20
Roll
-20
-10
0
10
20
A2
-C3 C3-
T4
T4-
A5
A5
-A6 A6
-T7 T7-
T8
T8-
G9
G9
-A1
0
Figure 4.7: Local axis bend (left) and roll angle (right) for non-covalent MD complexes
(upper panel) and covalent MD complexes and NMR-structures (lower panel). Parameters of
the MD-structure of I are reported in all graphs for comparison.
88 DNA Alkylation by duocarmycins
MD Simulations of the Non-covalent Drug-I Complexes
As expected, the non-covalent DSA-I and DSI-I adducts, constructed from the cova-
lent NMR structures, exhibit slightly larger rmsd’s from the initial models than those
of the covalent complexes (Table 4.3). The initial MD structure of NBOC-DSA- I,
for which no experimental structure is available, is derived from the covalent DSA-I
complex. The tert-butyl unit, which replaces the indole unit of DSA, is bulky and
penetrates less into the minor groove. Therefore, it is not surprising that the rmsd
of NBOC-DSA-I is higher than that of DSA-I or DSI-I (Table 4.3). The mutual
rmsd’s between the non-covalent drug-I complexes and I are small, ranging from 0.5
to 0.7 Å. Consistently, all these structures exhibit: (i) A narrow minor groove with the
narrowest value at the A6 site (Figure 4.5), (ii) high negative propeller twists in the
A-tract (Figure 4.5), (iii) increased local axis bend and roll angles at the ends of the
A-tract (Figure 4.7). (iv) A low helix twist at the T4-A5 step (Figure 4.6). The latter
is also observed in the covalent drug-I complexes, thus this seems to be an inherent
feature of the sequence studied here and not a distortion due to the drug as proposed
in ref [134]. The overall DNA-curvature ranges from 18◦ to 29◦, similar to that of I
and higher than that of the covalent drug-I complexes (Table 4.4, 4.5).
The local axis bends at the T4-A5 step are slightly larger than in I (by 1◦-2◦,
Figure 4.8) and exhibit larger fluctuations (Table 4.4, 4.5). The roll angles are positive
at the end of the A-tracts (T4-A5, T8-G9) and account for most of the local axis
bends. All other base steps are characterized by a roll angle close to 0◦. The propeller
twists are larger at the A5-T18 base pair than in I (Figure 4.6) in all three drug-I
complexes. We notice that the fluctuations of these quantities at the drug-binding
site are slightly larger compared to the ones of I, and, much larger than those of the
covalent complexes (Table 4.4,4.5). The minor groove widths of DSA-I and DSI-I
are very similar to I and wider at the T4 and A5 step with respect to the covalent
drug-I adducts (Figure 4.5). On the other hand, the minor groove of NBOC-DSA-I
is wider at the alkylation site and at the two subsequent steps than those of DSA-I,
DSI-I and I. We conclude that the overall oligonucleotide structure is only slightly
perturbed by the presence of the drugs as already pointed out in ref. [134], but most
by NBOC-DSA.
We now investigate the mode of binding of the three drugs. The rmsd’s, calculated
by fitting only the DNA scaffold, suggest that NBOC-DSA rearranges significantly in
the minor groove, whereas DSA and DSI remain close to their initial positions (Table
4.3). For DSA-I and DSI-I, the distance between the reactants (atoms C13(drug) and
N3(A19), d hereafter) fluctuates between 3Å and 4Å, leading to a reactive complex
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local axis bend DSA-I DSI-I NBOC-DSA-I
A2-C3 3.6 (1.7) 4.1 (2.0) 3.5 (1.7)
C3-T4 4.1 (2.1) 4.5 (2.5) 4.1 (2.2)
T4-A5 7.0 (3.4) 6.8 (3.8) 7.6 (3.6)
A5-A6 3.4 (1.8) 4.1 (2.4) 4.4 (2.6)
A6-T7 3.0 (1.6) 3.3 (1.7) 3.9 (2.2)
T7-T8 3.8 (1.9) 3.3 (1.9) 4.1 (2.1)
T8-G9 5.9 (2.4) 5.7 (2.5) 5.9 (2.7)
G9-A10 3.2 (1.8) 2.8 (1.6) 3.8 (2.0)
roll angle
A2-C3 2.4 (4.1) -0.41 (5.3) 3.5 (1.7)
C3-T4 4.9 (5.2) 2.4 (6.9) 4.1 (2.2)
T4-A5 11.7 (7.6) 13.0 (7.3) 7.6 (3.6)
A5-A6 -1.2 (5.8) 1.6 (6.0) 4.4 (2.6)
A6-T7 -0.7 (4.2) -1.6 (3.9) 3.9 (2.2)
T7-T8 0.0 (4.8) -2.7 (4.7) 4.1 (2.1)
T8-G9 12.0 (5.4) 11.9 (5.2) 5.9 (2.7)
G9-A10 -1.3 (4.7) -0.1 (5.2) 3.8 (2.0)
global curvature
17.7 (7.7) 15.3 (8.7) 29.4 (10.1)
Table 4.4: Local axis bend, roll angle and global curvature for non-covalent drug-DNA
adducts with standard parameters in parantheses
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local axis bend covDSA-I cov-DSI-I Free DNA (I)
A2-C3 3.7 (1.6) 4.0 (1.6) 3.5 (1.6)
C3-T4 2.8 (1.7) 2.9 (1.6) 3.7 (2.1)
T4-A5 4.8 (2.4) 4.8 (2.1) 6.0 (2.8)
A5-A6 3.9 (2.0) 3.8 (1.8) 4.1 (2.2)
A6-T7 4.0 (2.1) 3.6 (1.1) 3.3 (1.8)
T7-T8 3.8 (2.0) 3.6 (1.9) 4.1 (2.0)
T8-G9 6.6 (3.0) 6.0 (2.4) 5.7 (2.5)
G9-A10 3.2 (2.0) 2.9 (1.7) 3.3 (1.7)
roll angle
A2-C3 -0.3 (4.6) 0.1 (4.0) 3.5 (1.6)
C3-T4 1.2 (4.8) 2.9 (4.4) 3.7 (2.1)
T4-A5 11.2 (6.2) 10.5 (6.0) 6.0 (2.8)
A5-A6 0.1 (5.6) -0.6 (5.4) 4.1 (2.3)
A6-T7 1.5 (4.2) 0.8 (4.1) 3.4 (1.8)
T7-T8 0.4 (4.6) 0.1 (4.5) 4.1 (2.0)
T8-G9 11.0 (6.7) 11.4 (5.7) 5.7 (2.5)
G9-A10 0.5 (6.1) 1.8 (5.2) 3.3 (1.7)
global curvature
16.8 (7.6) 14.7 (6.9) 24.4 (9.6)
Table 4.5: Local axis bend, roll angle and global curvature of covalent drug-DNA adducts
and Free DNA (I) with standard deviations in parantheses
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Figure 4.8: Variation in local axis bend at the T4-A5 (left) and T8-G9 (right) step along
the first five normal modes. Upper panel: non-covalent adducts compared to I, lower panel:
non-covalent adducts compared to I
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DSA-I DSI-I NBOC-DSA-I
d(C13-N3(A19)) 3.6 (0.5) 3.5 (0.4) 4.8 (0.9)
d(C13-N3(G20)) 6.3 (0.5) 5.7 (1.1) 4.1 (0.6)
Table 4.6: C13-N3 distance for non-covalent drug-I MD structures. Both distance to A19
and G20 are given, standard deviations in parantheses.
between the drug and DNA (Table 4.3, Figure 4.10). Instead, the corresponding dis-
tance in NBOC-DSA-I fluctuates between 3 Å and 9Å, and d(C13(drug)-N3(G20))
oscillates between 3Å and 6.0Å (Table 4.6, Figure 4.10). Thus, this guanine nucle-
obase could be an alternative alkylation site for NBOC-DSA. So far, alkylation at
guanine sites has only been observed for a structurally related compound [168] and
not for NBOC-DSA.
Ring B of DSA and DSI forms basically the same hydrophobic interactions as the
covalent complexes, but is slightly shifted to the 5’-end of the modified strand (Table
4.7, Figure 4.11). The C28 methoxy-group of DSA forms additional contacts with
the minor groove. NBOC-DSA, in which ring B is substituted by a tert-butyl group,
forms less hydrophobic contacts with I. The three methyl groups are equivalent and
in contact with the sugar rings of A19 and A6 (Table 4.7). Ring A of DSA and DSI is
located further away from the alkylation site and forms less hydrophobic contacts to
the minor groove than in the correspondent covalent adducts. The C2-carbomethoxy-
N2(G20) H-bond [141] is mediated by one water molecule. Ring A of NBOC-DSA
forms tighter hydrophobic contacts than the other two drugs and a direct H-bond for
most of the simulated time.
Comparison among all the models
In this section, we compare selected features of the systems investigated by MD sim-
ulations. In the drug-I complexes, the hydrophobic contacts between ring B and
the minor groove are similar; those between ring A and DNA are shorter in the
covalent complexes. A superposition of covalent and non-covalent complex is pre-
sented in Figure 4.11. The only hydrogen bond present between G20 and the methyl-
carboxy-group is direct in the covalent complexes whereas it is mediated by one wa-
ter molecule in the non-covalent complexes. The two carbonyl groups are solvent
exposed in all systems (Figure 4.2).
The χ1 and χ2 torsion angles of DSA and DSI are very similar and larger than
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DSA NMR DSI NMR covDSA-DNA covDSI-I
C25-T18 3.78 (0.28) 3.67 (0.03) 3.99 (0.33) 3.86 (0.26)
C25-T7 3.83 (0.35) 3.73 (0.06) 4.02 (0.28) 3.69 (0.23)
C28-T8 3.89 (0.24) - 4.48 (0.28) -
C28-T17 4.01 (0.36) - 5.10 (0.64) -
C28-T18 3.91 (0.27) - 4.15 (0.37) -
C19-T18 4.23 (0.35) 4.18 (0.04) 4.75 (0.64) 4.11 (0.33)
C19-T7 3.67 (0.26) 3.97 (0.08) 4.05 (0.31) 4.04 (0.30)
C3-A5 4.66 (0.34) 4.79 (0.01) 4.35 (0.42) 4.67 (0.36)
C3-G20 4.00 (0.32) 3.89 (0.03) 4.12 (0.24) 4.13 (0.26)
C14-T21 3.76 (0.38) 3.76 (0.03) 3.90 (0.27) 3.90 (0.36)
H-bond O14 4.10 (1.00) 3.30 (0.81) 5.22 (0.28) 3.94 (1.10)
H-bond O15 3.63 (1.11) 4.59 (0.86) 3.21 (0.32) 5.89 (1.10)
DSA-I DSI-I NBOC-DSA-I
C25-T18 3.92 (0.28) 3.87 (0.28) C19-A6 4.94 (0.87)
C25-T7 4.12 (0.41) 3.91 (0.33) C19-A19 5.98 (1.73)
C28-T8 4.33 (0.50) - C20-A6 5.15 (0.84)
C28-T17 4.20 (0.49) - C20-A19 6.60 (1.69)
C28-T18 4.58 (0.61) - C21-A6 5.48 (0.82)
C19-T18 3.99 (0.39) 4.10 (0.32) C21-A19 5.86 (1.41)
C19-T7 3.90 (0.30) 3.91 (0.33)
C3-A5 5.30 (0.71) 4.80 (0.59) 4.3 (0.70)
C3-G20 5.51 (0.84) 5.55 (0.74) 5.91 (0.67)
C14-T21 6.80 (1.52) 6.83 (1.62) 5.21 (1.1)
H-bond O14 9.60 (1.10) 7.29 (1.00) 6.34 (1.3)
H-bond O15 7.71 (1.00) 9.04 (1.1) 4.31 (1.34)
Table 4.7: Selected hydrophobic contacts and H-bond distances between drugs and I mea-
sured as the minimal distance between drug-carbon atom and C1’, C2’ or C5’ of furanose
ring. Standard deviations are given in parantheses.
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Figure 4.11: Superposition of covalent (red) and non-covalent (blue) drug-I adducts. Left:
DSA-I, Right: DSI-I
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those of NBOC-DSA (Table 4.1). Furthermore, they are larger and fluctuate more
than those of the corresponding covalent drug-I complexes (Table 4.1). Thus, DSI
and DSA are more distorted and flexible in the free state than when bound to DNA.
We observe that spatial fluctuations of the non-covalent complexes are slightly
larger than those of the free nucleotide, and, much larger than those of the covalent
complexes. These findings are substantiated by an analysis of the large-scale mo-
tions. In fact, the latter are characterized by changes in the minor groove width and
the DNA curvature. The minor grooves open up and close again. The widths and the
curvature of the non-covalent complexes are fairly similar to those of I and they vary
by as much as 3Å and 15Å, respectively (Figure 4.9). This further confirms that the
drug does not affect very much the structure and dynamics of the DNA scaffold. In
the covalent adducts, the variation in minor groove width is much smaller (∆ width:
0.2-0.5 Å), whereas DNA curvature still varies considerably (∆ curvature: 14◦). The
latter is however due to enhanced fluctuation of the local axis bend at the T8-G9 step,
which is outside the drug-binding site (Figure 4.8). Thus, the formation of the cova-
lent bonds leads to a stiffening of the drug-binding site (Figure 4.8,4.9, Table 4.44.5).
We close this section by investigating the hydration of the drug-binding site. The
minor groove of the MD structure of I is fully hydrated and the water molecules form
the typical spine of hydration (Figure 4.12)[3, 169]. The presence of the drug leads
to removal of several ordered waters in the minor groove with respect to I (Figure
4.12). In DSA-I and DSI-I, A6 and T18 are fully dehydrated and A19 and A5 are
partially dehydrated as seen by the water occupancy (see Methods). In NBOC-DSA-
I, G20, T4, A19 and A5 have low water occupancy again showing that ring A of
NBOC-DSA is tighter bound to the minor groove than DSA and DSI. Covalent bind-
ing leads to further removal of water molecules from the minor groove in agreement
with ref. [134]. In covDSA-I, G20, T4, A19, A5, A6 and T18 are fully dehydrated.
In covDSI-I the same sites are fully dehydrated with the exception of T4, which has
some residual water occupancy at this site (Figure 4.13).
4.3.2 Alkylation Reactions
Reactions of DSA, DSI and NBOC-DSA with I
The MD structures produced in the previous section are here used to investigate these
alkylation reactions. Comparison between the reaction of NBOC- DSA with ade-
nine in DNA and adenine in water allows investigating the effect of the DNA scaffold
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Figure 4.12: Hydration in minor groove of non-covalent DSA-I (red), DSI-I (blue) and
NBOC-DSA-I drug-DNA adducts compared to free DNA (black) Occupancy corresponds to
time in which H-bond is present with respect to entire simulation time.
Figure 4.13: Hydration in minor groove of covalent covDSA-I (red) and covDSI-I (blue)
drug-DNA adducts compared to free DNA (black) Occupancy corresponds to time in which
H-bond is present with respect to entire simulation time.
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on the reaction barrier. Our computational tool here is the constrained hybrid Car-
Parrinello Molecular Mechanics/Molecular Dynamics method[13, 14]. The reactions
are believed to occur via an SN2 mechanism [133, 170] with the rate limiting step
being the attack of the N3 atom of A19 on the least substituted carbon atom of the cy-
clopropyl unit (C13). Simultaneously, the C9-C13 bond is elongated and eventually
broken, whereas the other two bonds in the cyclopropyl ring, d(C9-C10) and d(C10-
C13) get shorter. In the second step, which is faster[133], the carbonyl-oxygen in
O6 position is protonated. Thus, a plausible reaction coordinate for the rate limiting
step is the d(N3(A)-C13(drug)) distance (d hereafter), assuming a linear decrease of
this distance along the reaction pathway, making the approximation of a mono- di-
mensional reaction coordinate. We discuss the electronic and structural properties at
selected steps along the reaction coordinate in terms of Polarization Index (PI) and
D-RESP charges (see Methods)[14], bond-lengths and bond angles involving ring A.
In particular, we focus on the C9-C13 bond length, as this bond is broken during the
reaction. We start from conformations in which d= 3.3 Å. These are frequently en-
countered in the MD simulations of DSA-I and DSI-I, whereas they are found only
at times in NBOC-DSA-I (see above).
At 3.3 < d < 2.8Å, the bond lengths of the cyclopropyl group are in the order: (C9-
C13), d(C9-C10), d(C10-C13), and the angles in the strained 3-membered ring are
close to 60◦, as found experimentally in a structurally related compound (Cambridge
database, RUGGAB[171]). This suggests that, in this range of d, the structure of the
reactive moiety of the drug is not significantly perturbed. The C9-C13 bond is polar-
ized towards C9 in the three complexes (mostly in DSA-I, Table 4.3.2), while the N3
lone pair is polarized towards C13 (Figure 4.14. The D-RESP charge of N3 is slightly
negative.
At d= 2.6 Å, the d(C9-C13) becomes slightly longer (by 0.01 Å) and more polar-
ized towards C9 whereas the other two cyclopropyl-bonds get shorter. No significant
change is observed in the angles in the cyclopropyl unit. The N3 lone pair is larger
and more polarized (Figure 4.14) and its D-RESP charge is slightly decreased (Table
4.3.2).
At d= 2.4 Å, the d(C9-C13) gets further elongated and the bond-length fluctuates
significantly (Table 4.3.2). The (C13-C9-C10) and (C10-C13-C9) angles are smaller
than 50◦, whereas ∠(C13-C10-C9) becomes as large as 87◦. The charge on N3 is now
almost zero.
At d= 2.3Å the constraint force is close to 0 and at the next step (d= 2.2 Å), the sign
of the constraint force changes, indicating that the transition state is passed. Thus,
we take the d= 2.3 Åas a model of the TS. d(C9-C13) is about 2.0Å, d(C9-C10) is
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Figure 4.14: Wannier Centers for the three reactions of DSA, DSI and NBOC-DSA in DNA.
The reaction of NBOC-DSA in water is also shown for comparison.
further shortened and d(C10-C13) is slightly longer. ∠(C13-C9-C10) and ∠(C10-
C13-C9) are significantly smaller than 60◦, whereas ∠(C13-C10-C9) gets as large as
87◦. The largest C13-C10-C9 angle is observed in DSA-I, which features also the
longest C9-C13 bond. The C9-C13 bond is strongly polarized towards C9 and the
correspondent Boys orbital center resembles indeed more a lone pair localized on C9
(see Figure 4.18). This negative charge up-build at C9 can be stabilized by delocaliza-
tion over the aromatic system of ring A, as seen in the change of bond- lengths in the
6-membered ring of the indole-unit: d(C9-C8), d(C9-C4), d(C8-C7) and d(C6-C5)
get shorter whereas d(C8-C7) and d(C5-C4) get longer. The N3 lone pair is further
polarized towards C13 (Figure 4.14) and the D-RESP charge of this atom is less neg-
ative. The decrease of negative charge on this center during the reaction illustrates
qualitatively the charge transfer and tells about the proceeding of the reaction[14]. In
DSA-I the polarization of the N3 electron lone pair is the largest, consistent with the
highest D-RESP charge on N3 (Table 4.3.2).
Energetics: The free energy profiles are very similar for all three drugs, rang-
ing from 10.5kcal/mol - 13.8kcal/mol (Table 4.3.2). Our calculations underestimate
severely the experimental free energies, which range from 22-28kcal/mol, by 10kcal/mol.
The several possible causes of such dramatic difference between experimental and
theoretical values are discussed in the Discussion Section.
Drug-Conformation: In our classical simulation we observe a shift in the χ1 and
χ2 distribution when passing from the non-covalent to the covalently bound species.
Here, we confront these results to the QM/MM simulation, in which the torsional
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DSA-I N3-C13 distance [Å]
D-RESP charges 3.0 2.6 2.4 2.3
N3 -0.035 -0.015 0.019 0.032
Bond-lengths and bond angles
C9-C13 1.590 (.026) 1.660 (.050) 1.816 (.104) 2.057 (0.095)
C9-C10 1.558 (.019) 1.545 (.020) 1.526 (.012) 1.520 (.011)
C10-C13 1.467 (.011) 1.461 (.010) 1.464 (.011) 1.475 (.014)
C9-C8 1.467 (.009) 1.461 (.011) 1.443 (.012) 1.422 (.009)
C8-C7 1.379 (.008) 1.385 (.010) 1.388 (.009) 1.399 (.010)
C7-C6 1.444 (.011) 1.439 (.013) 1.441 (.012) 1.430 (.012)
C6-C5 1.446 (.011) 1.441 (.012) 1.440 (.012) 1.437 (.012)
C5-C4 1.412 (.009) 1.411 (.008) 1.416 (.010) 1.422 (.009)
C9-C4 1.458 (.011) 1.454 (.012) 1.440 (.013) 1.425 (.011)
N3-C13-C9 157 (5) 161 (5) 161 (7) 160 (5)
C13-C9-C10 56 (1) 54 (1) 51 (2) 46 (2)
C10-C13-C9 61 (1) 59 (2) 54 (3) 48 (3)
C13-C10-C9 63 (1) 67 (3) 75 (5) 87 (5)
DSI-I N3-C13 distance [Å]
D-RESP charges 3.0 2.6 2.4 2.3
N3 -0.014 0.009 0.044 0.030
Bond-lengths and bond angles
C9-C13 1.592 (.033) 1.645 (.041) 1.786 (.112) 1.971 (.109)
C9-C10 1.541 (.018) 1.540 (.017) 1.532 (.013) 1.520 (.009)
C10-C13 1.480 (.014) 1.473 (.010) 1.466 (.007) 1.474 (.015)
C9-C8 1.474 (.009) 1.464 (.011) 1.447 (.009) 1.433 (.009)
C8-C7 1.383 (.007) 1.383 (.010) 1.388 (.007) 1.393 (.008)
C7-C6 1.441 (.013) 1.447 (.012) 1.443 (.009) 1.431 (.008)
C6-C5 1.444 (.011) 1.449 (.014) 1.443 (.009) 1.440 (.009)
C5-C4 1.407 (.008) 1.412 (.010) 1.414 (.008) 1.420 (.006)
C9-C4 1.458 (.013) 1.455 (.014) 1.440 (.009) 1.432 (.010)
N3-C13-C9 158 (7) 171 (5) 169 (5) 164 (4)
C13-C9-C10 56 (1) 55 (1) 52 (2) 48 (2)
C10-C13-C9 60 (1) 59 (1) 55 (3) 50 (3)
C13-C10-C9 64 (2) 66 (2) 73 (6) 82 (5)
NBOC-I N3-C13 distance [Å]
N3 -0.056 -0.055 -0.007 0.018
Bond-lengths and bond angles
C9-C13 1.591 (.032) 1.626 (.032) 1.791 (.085) 1.990 (.105)
C9-C10 1.573 (.022) 1.559 (.021) 1.536 (.015) 1.529 (.009)
C10-C13 1.470 (.009) 1.462 (.012) 1.456 (.006) 1.468 (.012)
C9-C8 1.447 (.011) 1.464 (.011) 1.439 (.015) 1.424 (.007)
C8-C7 1.374 (.008) 1.377 (.008) 1.388 (.008) 1.395 (.005)
C7-C6 1.444 (.011) 1.439 (.011) 1.431 (.010) 1.427 (.008)
C6-C5 1.451 (.013) 1.446 (.012) 1.441 (.010) 1.439 (.009)
C5-C4 1.409 (.008) 1.411 (.007) 1.416 (.009) 1.421 (.006)
C9-C4 1.466 (.013) 1.462 (.012) 1.443 (.010) 1.433 (.009)
N3-C13-C9 166 (6) 157 (4) 156 (4) 156 (4)
C13-C9-C10 56 (1) 55 (1) 51 (2) 47 (2)
C10-C13-C9 62 (1) 60 (1) 55 (3) 50 (3)
C13-C10-C9 62 (2) 65 (2) 74 (4) 83 (5)
Table 4.8: D-RESP charges, bond-lengths [Å] and angles [◦] for selected distances along the
reaction coordinate
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DSA-I DSI-I NBOC-DSA-I
∆G#theoretical 10.5 ±3.4 13.8±3.6 12.1±2.4
∆G#experimental 22.7 24.5 26.8-28.2
Table 4.9: Activation free energy for reactions of DSA, DSI and NBOC-DSA in DNA
[kcal/mol]
angle distribution does not rely on classical parametrization. Even though the total
sampling time is very short (7.5ps), we observe a distribution, which is similar to the
classical one and almost as broad (Figure 4.15). The distribution does not change
significantly along the reaction.
Reaction between adenine and NBOC-DSA (R4)
As a reference reaction in water, we choose the smallest compound NBOC-DSA,
which is stable in water at pH 7 [172]. The simulation is based on a classical MD
simulations in which d is constrained at 3.3Å. In the MD-simulation, the N3(A) atom
has no neat solvation shell because of its vicinity to NBOC-DSA, whereas N1, which
has a similar charge (-0.6e), is fully solvated with two water molecules within 3.5Å.
We follow the reaction using the same reaction coordinate as for the reaction towards
I, analyzing the same steps along the reaction coordinate in terms of PI, D-RESP
charges and bond lengths and angles (Table 4.3.2). In particular, ∠N3-C19-C9 can
be taken as a measure for the ideal atom positioning for SN 2 reactions, in which at-
tacking and leaving group are in-line and the central carbon atom adopts a trigonal
bipyramidal structure. This angle varies significantly during the reaction. Instead,
in the reaction of NBOC-DSA-I, the ∠N3- C19-C9 angle changes very little (Table
4.3.2), because of geometrical constraints.
We focus on the difference between the two reactions. The latter is manifest in the
activation free energy, which is 4kcal/mol higher in water than in DNA. This corre-
sponds to a rate acceleration of roughly 3 orders of magnitude. Although the reaction
barrier is largely underestimated, our finding is in qualitative agreement with the fact
that DNA catalyzes the reaction.
At d= 3.0 Å, the C9-C13 bond is less polarized in R4 (Figure 4.14), suggesting that
this polarization is a key feature for the increase in reactivity of the drug caused by
I. Poisson-Boltzman calculation of the electrostatic potential at the C9 and C13 sites
supports this picture (Table 4.11): In I, the electrostatic potential is more negative at
the C13 position than at the C9 position, leading to a field, which polarizes this bond
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Figure 4.15: Dihedral angle distribution for the classical MD simulation in the non-covalent
(upper panel) and covalent (lower panel) drug-DNA complexes.
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R4 N3-C13 distance [Å]
D-RESP charges 3.0 2.6 2.4 2.3
N3 -0.270 -0.229 -0.313 -0.154
Bond-lengths and bond angles
C9-C13 1.580 (.036) 1.626 (.036) 1.768 (.087) 2.168 (.147)
C9-C10 1.559 (.027) 1.554 (.022) 1.535 (.020) 1.524 (.012)
C10-C13 1.478 (.012) 1.467 (.009) 1.466 (.011) 1.486 (.014)
C9-C8 1.477 (.015) 1.466 (.010) 1.449 (.015) 1.412 (.008)
C8-C7 1.379 (.009) 1.377 (.009) 1.388 (.011) 1.407 (.008)
C7-C6 1.441 (.012) 1.440 (.011) 1.441 (.014) 1.426 (.009)
C6-C5 1.447 (.020) 1.446 (.010) 1.444 (.015) 1.432 (.009)
C5-C4 1.408 (.010) 1.412 (.007) 1.413 (.010) 1.423 (.009)
C9-C4 1.464 (.017) 1.461 (.010) 1.447 (.015) 1.421 (.010)
N3-C13-C9 165 (9) 155 (7) 153 (6) 146 (6)
C13-C9-C10 56 (1) 55 (1) 52 (2) 43 (3)
C10-C13-C9 61 (2) 60 (2) 56 (3) 45 (4)
C13-C10-C9 63 (2) 65 (2) 72 (4) 92 (7)
Table 4.10: D-RESP charges, bond-lengths [Å] and angles [◦] for selected distances along
the reaction coordinate for the reactions R1-R4 in water
and renders it more reactive. In R4, the electrostatic potential is at both sites very
similar and fluctuates around 0 (Table 4.11). The N3-lone pair of adenine is on the
other hand more polarized in R4.
In the following d= 2.8 Å, 2.6 Åand 2.4 Åthe polarization of this electron lone pair
remains almost constant in R4 whereas it increases in I and at d= 2.4 Å, the po-
larization of N3 towards C13 is very similar in both reactions. d(C9-C13) undergoes
similar changes in both environments and increases steadily whereas ∠(C13-C9-C10)
and ∠(C10-C13-C9) angles decrease, ∠(C13-C10-C9) increases and the absolute val-
ues compare very well.
At d=2.3 Å, d(C9-C13) is around 2Å, and longer in R4 than in I. In both reactions,
the N3 lone pair is largely polarized towards C13, indicating the formation of a bond
between these two atom centers. The D-RESP charge on N3 gets less negative during
both reactions. In R4, the D-RESP is however still negative at the TS whereas in I,
N3 gets slightly positive.
QMMM calculations on model systems in water
We conclude this Section by reporting QM/MM simulations of selected systems in
aqueous solution, using the same computational scheme. Starting from R4, discussed
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NBOC-DSA-I R4
d(N3-C13) [Å] 3.3 3.0 3.3 3.0
C9 -6.65 (0.32) -6.72 (0.22) 0.004 (0.047) -0.111 (0.02)
C13 -7.62 (0.32) -7.86 (0.24) 0.005 (0.050) -0.27 (0.04)
∆ 0.97 1.14 ∼ 0.0 0.16
DSA-I DSI-I NBOC-DSA-I
C9 -5.3 (1.0) -5.6 (1.1) -4.3 (0.8)
C13 -6.1 (1.4) -6.4 (1.5) -4.8 (1.1)
∆ 0.89 0.84 0.50
Table 4.11: Electrostatic Potential [kT/e] at C9 and C13 sites of drugs. A constant dielectric
constant for DNA and water and an even counter ion distribution are assumed, results are only
of qualitative nature. (i) QM/MM calculation of NBOC-DSA in I and with adenine in water
(R4). (ii) MD-simulation of non-covalent drug-I complexes.
above, we decrease the complexity of the system gradually (R3-R1, Figure 4.3). First,
we reduce the NBOC-DSA unit by omitting the pyrrole ring condensed to the indole
unit (R3). Then we substitute the adenine by ammonia (R2) and finally, we inves-
tigate the reaction of cyclopropane with ammonia (R1). Comparison between these
reactions provide insights on the role of the pyrrole ring, adenine and the indole unit
for the reactivity. Some features of R4, which are related to the influence of the pyr-
role ring, are also discussed in this section.
The systems undergo first classical MD and they are fully solvated. In particular, the
nucleophile nitrogen of ammonia and adenine interacts on average with 1.0 and 0.8
waters, as obtained from the radial distribution functions.
In the QM/MM simulation, at d= 3.0 Å, the nucleophile (either NH3 or A) moves
freely around the cyclopropyl unit with little orientational preference in the timescale
investigated as can be seen in ∠(N3-C13-C9), which ranges from 105◦-163◦. The
standard deviations are large, indicating high mobility in this degree of freedom. The
cyclopropyl-unit present in R2 and R3 renders the C-C bonds of the cyclopropyl unit
asymmetric: the C9-C13 and C9-C10 bonds are longer than C10-C13 (Table 4.3.2).
Instead, as expected, the cyclopropyl-unit is almost symmetrical in R1: the slight dif-
ferences among the three C-C bond-lengths are possibly caused by inhomogeneities
in the solvent electric field and the presence of the ammonia. As a result, the bonds in
the cyclopropyl unit are slightly polarized in R2, R3 and R4, whereas in R1 they are
not polar (Figure 4.16).
In the three systems, the C-C angles are close to 60◦, which leads to a considerable
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Figure 4.16: PI for nitrogen nucleophile (left) and C9-C13 bond (right) for R1-R4
ring strain. This strain is partially lifted thanks to so-called banana shaped orbitals,
which are displaced outwards with respect to the straight bond (Figure 4.17). The
lone pair of the ammonia-nitrogen (R1, R2) is less polarized than the N3(A) lone pair
(R3, Fig. 6). The D-RESP charges at this center are largely negative in all reactions.
At d= 2.6 Å, the TS state is reached for R2 and R3. The nucleophile adopts an
orientation in which the N3 or the N3 electron lone pair (represented by the Boys-
orbital represented in Figure 4.18) points towards the C13 atom and all three atom
centers involved in the reaction, namely N3, C13 and C9 form a close to ideal angle,
which ranges from 158◦-170◦.
The standard deviations of this angle are also decreasing, showing that the fluctu-
ations are getting smaller in this degree of freedom (Table 4.3.2). In R2 and R3, the
C9-C13 bond is further elongated and the other two C-C bonds get slightly shorter.
The C-C bonds are instead almost equivalent in R1. The C9-C13 bond is also more
polarized towards C9, whereas the N of ammonia and N3(A) are more polarized
towards C13 (Figure 4.16). The D-RESP charge of N3(A) in R3 has decreased sig-
nificantly and is close to 0 whereas in R2, the charge on the ammonia-nitrogen is still
highly negative. However, at the next step after the TS, d= 2.5 Å the D-RESP charge
is positive. At d= 2.1Å, the TS is reached also for R1. The C-C bond and C-C-C
angels are much less distorted than those of R2, R3 (Table 4.3.2). The N3 lone pair is
much less polarized towards C13 and the C9-C13 bond towards C13 than in R2-R3
(Figures 4.16, 4.17, and 4.18). The D-RESP charge is still highly negative at the TS.
Energetics: The activation free energy decreases dramatically from R1 to R3 and
R2 (Table 4.13). That of R4 is larger than R3 by few kcal/mol. No experimental data
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Figure 4.17: Boys-orbital centers in R1 at two snapshots for d=3.0Å (left) and d=2.1Å.
Figure 4.18: Boys-orbital centers in R2 at two snapshots for d=3.0Å (left) and d=2.5Å.
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R1 N3-C13 distance [Å]
D-RESP charges 3.0 2.6 2.1
N3 -0.490 -0.320 -0.236
Bond-lengths and Angles
C9-C13 1.520 (.029) 1.526 (.020) 1.603 (.035)
C9-C10 1.531 (.030) 1.523 (.014) 1.525 (.035)
C10-C13 1.517 (.025) 1.510 (.011) 1.487 (.010)
N3-C13-C9 159 (8) 161 (5) 161 (4)
C13-C9-C10 59 (2) 59 (1) 57 (1)
C10-C13-C9 60 (1) 60 (1) 59 (1)
C13-C10-C9 60 (1) 60 (1) 64 (2)
R2 N3-C13 distance [Å]
D-RESP charges 3.0 2.6 2.5
N3 -0.322 -0.362 0.039
Bond-lengths and Angles
C9-C13 1.598 (.040) 1.689 (.066) 2.184 (.232)
C9-C10 1.560 (.027) 1.557 (.021) 1.547 (.016)
C10-C13 1.473 (.019) 1.462 (.011) 1.472 (.014)
C9-C8 1.470 (.016) 1.453 (.012) 1.424 (.011)
C8-C7 1.370 (.010) 1.376 (.009) 1.389 (.007)
C7-C6 1.453 (.018) 1.444 (.012) 1.429 (.008)
C6-C5 1.467 (.018) 1.456 (.014) 1.433 (.010)
C5-C4 1.356 (.012) 1.365 (.007) 1.392 (.012)
C9-C4 1.451 (.017) 1.435 (.018) 1.403 (.009)
N3-C13-C9 107 (10) 170 (4) 157 (11)
C13-C9-C10 56 (1) 53 (1) 42 (6)
C10-C13-C9 61 (2) 59 (2) 45 (7)
C13-C10-C9 63 (2) 68 (3) 93 (12)
R3 N3-C13 distance [Å]
D-RESP charges 3.0 2.6 2.5
N3 -0.061 -0.007 0.124
Bond-lengths and Angles
C9-C13 1.628 (.062) 1.719 (.085) 2.069 (.138)
C9-C10 1.570 (.030) 1.556 (.024) 1.542 (.011)
C10-C13 1.462 (.019) 1.463 (.014) 1.467 (.013)
C9-C8 1.457 (.022) 1.446 (.012) 1.427 (.006)
C8-C7 1.372 (.020) 1.376 (.010) 1.389 (.006)
C7-C6 1.445 (.020) 1.443 (.012) 1.437 (.008)
C6-C5 1.455 (.184) 1.449 (.012) 1.437 (.007)
C5-C4 1.363 (.161) 1.367 (.086) 1.385 (.009)
C9-C4 1.444 (.022) 1.433 (.014) 1.408 (.007)
N3-C13-C9 163 (5) 158 (10) 156 (4)
C13-C9-C10 54 (2) 53 (2) 46 (3)
C10-C13-C9 60 (2) 58 (3) 49 (4)
C13-C10-C9 66 (3) 69 (4) 85 (8)
Table 4.12: D-RESP charges, bond-lengths [Å] and angles [◦] for selected distances along
the reaction coordinate for the reactions R1-R4 in water
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R1 R2 R3 R4
∆G# 46.8 ±2.3 6.8±3.8 10.6 ±4.7 16.1 ±4.0
Table 4.13: Activation free energy for R1-R4 in water [kcal/mol]
is available. Based on the previous analysis, we can identify the features responsible
for such ordering. The higher reactivity of R2, R3 and R4 with respect to R1 can be
explained by the efficient delocalization of the negative charge in the aromatic system
at the TS. This is illustrated again by the increase in aromaticity in the 6-membered
ring of the indole unit, as shown by the similarity of the C- C bond lengths at the
TS; specifically, the C9-C8, C7-C6, C6-C5 and C9-C4 bonds are shortened, whereas
the C8-C7 and C5-C4 bonds get elongated (Table 4.3.2). The larger activation free
energy of R4 relative to R3 is caused by the less aromatic character of the 6- mem-
ber ring of NBOC-DSA at the TS. This is evident by the fact that the C9-C4 bond
is considerably shorter in R3 than R4 (Table 4.3.2). The decrease in aromaticity,
in turn, delocalizes less efficiently the negative charge. This decrease is caused by
the presence of the condensed aromatic pyrrole ring, which stabilizes the electron
delocalization depicted in Figure 4.19, relative to other resonance structures. R2 is
more reactive than R3 possibly because ammonia is a slightly better nucleophile than
adenine. R2 is far more reactive than R1 as the indole unit stabilizes significantly
the transition state by aromatic conjugation, and better delocalization of the negative
charge on its electronegative groups (O6).
4.4 Discussion
We have presented a theoretical investigation of the key steps of the binding of duo-
carmycins to DNA. Classical MD simulations on the 10 ns timescale have provided
the mode of binding of non-covalent complexes (i.e. before the reaction takes place)
between the DSA, DSI, and NBOC-DSA and the oligonucleotide I. Our computa-
tional setup for the MD has been validated by performing MD simulations on the
NMR adducts, which compare well with the experimental data. The investigation has
been complemented by a QM/MM study of the rate-limiting step of the alkylation
reaction performed by the drugs. We find that NBOC-DSA binds less tightly than
DSA and DSI to I because of the presence of the tert- butyl unit, which is shorter and
bulkier than the indole unit of the other two drugs (Figure 4.1). The tert- butyl unit
penetrates therefore less into the minor groove and the interactions involve also fewer
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Figure 4.19: Resonance structures, which are able to delocalize the negative charge up-
build at C9. (1) ground-state resonance structure, (2) first resonance structure, delocalization
over C9-C8, (3) second resonance structure, delocalization over C9-C4. In NBOC-DSA the
second resonance structure seems to be hampered by the presence of the condensed pyrrole
ring.
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DNA residues. As a result, reactive conformations, in which the cyclopropyl moiety
of the drug is in close contact (about 3 Å) with the reactive adenine nucleobase, are
frequently encountered only for DSA and DSI. In addition, NBOC-DSA binds rather
unspecifically to I relative to the other two, as the drug cyclopropyl interacts also with
N3(G20).
The structures of all the systems investigated here are similar and differ substan-
tially from that of B- DNA, as expected for an A-tract containing oligonucleotide. The
drugs bind to I by removing two to three ordered water molecules (occupancy < 20%,
Figure 4.12,4.13). Formation of the covalent adduct causes the removal of a further
number of water molecules (5 to 6 fully dehydrated sites). The DNA structure is not
affected by drug binding. Thus, we expect that in the binding process a free energy
cost is associated to DNA dehydration (counterbalanced by the free energy of drug
binding), whilst that associated to conformational changes of the DNA scaffold is
probably negligible. In all the DNA systems considered here, the large-scale motions
involve the bending of the entire DNA double helix and the opening and closing of
the DNA minor groove. The latter motion is slightly larger in the non-covalent com-
plexes than in I, and it is much smaller in the covalent ones (Figure 4.8). The drugs’
conformation changes when passing from the non-covalent to the covalent adducts.
The torsional angles χ1 (C7-C8-N12-C16) and χ2 (C8-N12-C16-O16) are used to
describe the conformational properties of the drugs. In the non-covalent adducts, the
average χ1 and χ2 angles in DSA and DSI are very similar and larger than those in
NBOC-DSA. In the corresponding covalent drug-DNA adducts, the average χ1 is
smaller and the standard deviation are also much lower. Thus, the drug is more flexi-
ble and distorted in the non-covalent than in the covalent complex. At the speculative
level, we argue here that the different mobilities of covalent and non covalent com-
plexes could be relevant for molecular recognition processes and the drug/DNA reac-
tivity. In the covalent complexes, the smaller minor groove width relative to the free
oligonucleotide, along with the relative rigidity of the entire complexes might play
a role for their interaction with the duocarmycin-DNA adduct recognizing protein,
DARP[173]. On the other hand, the relatively large fluctuations of the non-covalent
complex could help to trap the DNA in a reactive conformation, as suggested by Ref.
[145] The χ1 and χ2 values of the non-covalent complexes differ by only few degrees.
This observation argues against the ’shape induced activation’ mechanism, in which
the difference between such angles play a crucial role for the alkylation [143, 133].
The alkylation reactions have been described using constrained hybrid Car-Parrinello
Molecular Mechanics/Molecular Dynamics simulation [13, 159]. The reaction is fol-
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lowed using the d(N3(A)- C13(drug)) distance as reaction coordinate. The calcula-
tions are based on reactive conformations of the non-covalent drug-DNA structures, in
which the drugs are in a favourable orientation and in close contact with the oligonu-
cleotide for the SN 2 reaction. These are frequently found in the MD simulations of
DSA-I and DSI-I (Figure 4.10), whereas they are found only at times in NBOC-DSA-
I. Thus, it appears that DSA and DSI have been designed so as to have an optimal
interaction with the DNA scaffold.
During the reaction, the C9-C13 bond of the cyclopropyl unit gets progressively
longer and more polarized towards the C9, while the other two bonds in the 3-
membered rings get slightly shorter. The N3(A19) electron lone pair gets more polar-
ized towards the C13 and the negative charge at N3 slowly decreases until it eventu-
ally becomes positive at the transition state. At the transition state the C9-C13 bond is
broken (Table 4.3.2) and the corresponding electronic pair is mainly localized on C9.
The negative charge up-build at this center can be efficiently stabilized by delocalisa-
tion over the aromatic system. As a result, the aromaticity of the ring system increases
(Table 4.3.2) following closely the scheme in Figure 4.3. The distribution of the tor-
sional angles χ1 and χ2 in DSA and DSI are very similar and the average values are
slightly larger than in NBOC-DSA (Figure 4.15). Despite the short simulation time,
they are similar with the classical MD simulation, suggesting that the parametrization
of the drug provide a reliable description of the drugs’ conformational properties.
The calculated activation free energy profiles are very similar for all three drugs and
severely underestimate the experimental values. Several can be the factors leading
to such large discrepancy between theory and experiment: (i) The accuracy of the
methodology used. It is well known that the BLYP approximation for the exchange
correlation functional may largely affect the transition state energies. However, this
does not seem to be the case for several chemical and enzymatic reactions[15] so
far investigated with this method. To further address this issue, we have performed
test calculations on R2 with a different recipe for the exchange-correlation functional,
the B3LYP, with a localized basis set and implicit model of the solvent (Table 4.14).
The calculated free energy is still off by 7 kcal/mol. The severe underestimation is
however consistent with other theoretical studies on SN 2 reactions, in which differ-
ent DFT functionals are compared to higher level ab initio calculations. Indeed, the
transition state, where two electrons are delocalized over three atom centers result-
ing in a highly delocalized exchange hole, is poorely described by pure DFT meth-
ods and the TS results to be too stable, which leads eventually to a lower reaction
barrier[174, 175, 176, 177]. Consistently, Barone and coworkers[178], performing
the reaction on a very similar, but protonated NBOC-DSA-derivative in solution, ob-
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B3LYP BLYP B3LYP (PCM) BLYP (PCM)
∆E# 18.8 16.4 9.6 6.3
Table 4.14: Gaussian calculations for R2 at BLYP and B3LYP level in vacuo and with im-
plicit solvent (PCM). Geometry optimization at B3LYP level with single point calculations at
BLYP level. Activation free energy in [kcal/mol].
tain an error within experiment of 12 kcal/mol for the reaction with methanol. (ii) The
time-scale investigated. Because the QM/MM simulation is necessarily short, the re-
sults depend on the conformational properties and flexibility of the DNA scaffold as
well as on the location of the counter ions [12].
Comparison with the correspondent reaction in water for the smaller of these
drugs, NBOC-DSA, provides insights on the effect of the DNA scaffold on its re-
activity. NBOC-DSA reacts with DNA but it is stable at pH 7 towards adenine. We
find that: (i) The C9-C13 bond is more polarized in DNA than in water and therefore
more reactive in the biomolecular frame, (ii) N3 of adenine is less negative in DNA
than in water, which could render the charge transfer more easy in DNA and (iii) the
activation free energy is 4kcal/mol higher in water than in DNA. This corresponds
to a rate acceleration of roughly 3 orders of magnitude. Thus, although the also the
activation free energy of the model reaction is smaller than the experimental data, our
calculations are qualitatively in agreement with experiment, in that the DNA frame
catalyzes the reaction.
Finally, comparison of the reaction in water with those between the simple reac-
tions in Figure 4.3 (R1-R3) suggests that: (i) the presence of the condensed pyrrole
ring leads to a less efficient aromatic stabilization of the negative charge over the
aromatic indole ring. A similar energetic effect has been seen in a recent study on
the acid catalysed reaction of duocarmycin analogues [178]. Indeed, in that study,
the electronegative pyrrole ring attracts the positive charge from the protonated C6-
carbonyl group, lowering so the electrophilicity of the cyclopropyl unit. (ii) Ammonia
is a better nucleophile than adenine. (iii) The indole unit stabilizes significantly the
transition state by aromatic conjugation, as seen by the variation in the bond lengths
in the 6- membered ring of the indole unit, which tend to become all of the same
length. The same effect is seen in the study of ref [178], even though in this study,
the compound is already protonated. The good agreement can be due to the fact the
number of electrons in the pi-system is conserved.
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4.5 Conclusions
Molecular simulation approaches have been used to investigate the key steps of the
alkylation reaction of three duocarmycins. Several conclusions can be drawn by our
study: (i) The experimentally observed DNA catalytic power might be due, at least in
part, to a polarization of the biomolecular scaffold over the drugs. This effect may be
reminiscent of the electrostatic preorganization concept in enzymatic catalysis, with
the important difference that here the polarization seems to affect more the ground
state than the TS [8]. Instead, our calculations do not support the so-called ’shape
induced activation’ mechanism, in which the conformational properties of the drug
play a pivotal role for catalysis [143]. (ii) The chemical nature of the drug influences
the structure of the complex, thus affecting its reactivity; (iii) the DNA scaffold does
not rearrange significantly upon accommodating the substrate.
Chapter 5
Final Remarks & Outlook
5.1 Conclusions
Molecular simulations of DNA have now reached a rather mature phase. On the one
hand side, classical molecular dynamics of simulations have revealed itself as an ex-
tremely powerful tool to describe DNA structure, dynamical properties and energetics
of nucleic acids [3, 5, 37, 38]. On the other hand, quantum chemical calculations on
nucleodides/nucleosides in the gas [179, 180, 181, 182] and crystal phase [11] have
provided insights on the energetics along with details of the electronic structure.
QM/MM studies have first been applied to investigate the hydrolysis of the glyco-
sylic bond of uracyl residues erroneously incorporated in DNA [183]. In this thesis,
we have used such a technique applied to drug/DNA complexes as an approach which
could further expand the scope of molecular simulations of drug/target interactions.
By focusing on two very important anticancer drugs we have addressed rather differ-
ent issues.
In the first part of my study, I have investigated the interactions between the drug
cisplatin and DNA. Cisplatin induces severe distortions in the DNA structure, which
lead to a large kink at the platinated site along with a local conformational change
from B-DNA to A-DNA. Platinated DNA-complexes are recognized by the HMG-
domain of HMG-containing proteins. In my QM/MM simulation, the structure of
the platinated DNA dodecamer rearranges significantly towards structural determi-
nants of the solution structure as obtained by NMR spectroscopy [90]. The calculated
195Pt chemical shifts of the QM/MM structure relative to cisplatin in aqueous solu-
tion are in qualitative agreement with the experimental data [128, 129]. The QM/MM
structure of the platinated/DNA HMG complex, on the other hand, remains rather
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similar to the X-ray structure, consistent with its relatively low flexibility. Docking
of [Pt(NH3)2]2+ onto DNA in its canonical B-conformation causes a large axis bend
and a rearrangement of DNA as experimentally observed in the platinated adducts.
Our study shows that the QM/MM approach proves to give reliable results for Pt-DNA
complexes. Thus, this method could be very useful in cases where the incorporation
of new compounds into classical force fields is combersome as for cisplatin and its
derivatives. Short QM/MM molecular dynamics simulation can be used as refine-
ment technique in order to reproduce the correct coordination geometry and allow
for studying the electronic structure of the complex bound to DNA. A more accurate
ab-initio treatment of the Pt-moiety can be very helpful in understanding slight elec-
tronic and structural differences between different compounds.
My second study has exploited the power of QM/MM method in the possibility to
study chemical reactions while including the entire biomolecular frame. Many meth-
ods exist, which take solvent and environmental effects into account. However, most
of these approaches do not take into account explicitly either the DNA scaffold, and/or
temperature effects and/or the solvent. These effects are automatically incorporated
in the hybrid Car-Parrinello QM/MM. In case of duocarmycin, DNA-binding follows
a two step mechanism, the first one yielding the non-covalent drug-DNA complex and
the second one producing the covalent drug-DNA adduct. Even though a wealth of
kinetic data exists about hydrolysis in neutral and acidic environment, little is known
about the non-covalent binding process. We have performed therefore also extensive
classical molecular dynamics on both the non-covalent and the covalent drug-DNA
complexes. Our classical mechanics simulation suggest that non-covalent binding
and positioning of the drug in the minor groove is of great importance to the drug
activity. Our QM/MM calculations, on the other hand, show that the biomolecular
frame polarizes the drugs significantly and renders them more reactive with respect
to the reaction in water. Furthermore, QM/MM simulation of model compounds in
water suggest that the nature of the condensed rings in the drugs affects largely the
intrinsic reactivity of the drug.
The accuracy of the activation free energies depends largely on the exchange-
correlation functional. The BLYP gradient correction [52, 53], used here, has proven
to be very reliable for a variety of enzymatic reactions, yet it underestimates the bar-
riers in this work. This might be caused by the poor description of the exchange hole
at the TS, in which 2 electrons are delocalized over 3 atom centers [176, 177]. Other
parametrizations, notably the B3LYP performs only slightly better, whereas the PBE0
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[184, 185] yields results comparable to BLYP for a similar reaction [178].
5.2 Future Research
Several lines of research would be interesting to pursue:
1. Action of second generation drugs
The use of cisplatin is severely limited due to their intrinsic toxicity and re-
sistance problems. A great effort is devoted therefore to the design of new
Pt-drugs. The QM/MM docking of 2nd - and 3rd generation Pt-based drugs
on DNA structure may help to gain insights on the structural properties of the
platinated lesion. In this respect, I would like to mention that during the last
year, our group has started a collaboration with the group of Prof. Ruggerone
of the Dipartimento di Fisica in Cagliari, and the experimental group of Prof.
Reedijk at the Leiden Institute of Chemistry, on the interaction between drugs
other than cisplatin and DNA.
2. Use of different functionals
Use of other functionals than BLYP, such as BP and PBE, might improve both
the structural properties (e.g.the bond-lengths in Pt complexes, which could
lead to an improvement in the calculated 195Pt chemical shifts) as well as the
energetics. Especially in case of chemical reactions, such as the SN2 reaction
studied here, an improvement in the estimate of the TS is desirable.
3. Non-covalent Drug Binding
Our MD simulations of the non-covalent duocarmycin-DNA adducts have shown
that correct binding of the drug in the minor groove prior to alkylation con-
tributes to the different reactivity observed in the three drugs studied here. The
QM/MM simulations of the alkylation reaction are very similar for all the three
drugs. Within the limitations of the methodology as discussed above, we sug-
gest that the difference in reactivity arises in part also from the non-covalent
binding process.
The diffusion of the drugs towards DNA could be studied by means of meta-
dynamics simulations [186]. This method allows for inclusion of collective
coordinates, which characterize the conformational transition of the system un-
der investigation. The system evolves according to these collective coordinates,
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exploring the conformational space around them as in conventional MD. A his-
tory dependent potential term fills the minima of the free energy surface (FES)
during the dynamics and allows for an efficient exploration of the FES as a
function of the collective coordinates.
Future work could include the definition of a suitable set of collective coordi-
nates and the simulation of the binding and dissociation process of duocarmycin
to the DNA minor groove. These simulations could give insight into the recog-
nition and binding process and they could help to identifying the structural
features of the drug, which are most important for the binding process.
4. Drug-DNA/protein interactions
The antitumor activity of cisplatin-derived drugs seems to be correlated to the
binding affinity ot the platinated DNA towards HMG domain containing pro-
teins [99]. Both X-ray and NMR structure of the oxaliplatin-DNA complex ex-
ist (pdb-entries 1PG9, 1IHH, respectively [187, 188]). Docking of the HMG A
domain on these structures followed by MD-simulations could give insight into
structural and energetic differences responsible for the eperimentally known
binding constants.
Similar studies for duocarmycin-DNA adducts would also be of large inter-
est but they are still outside reach, since no structural data about the nature of
DARP exists so far.
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